Quarterlytics / Healthcare / Biotechnology / Terns Pharmaceuticals

Terns Pharmaceuticals

tern · LSE Healthcare
Claim this profile
Ticker tern
Exchange LSE
Sector Healthcare
Industry Biotechnology
Employees 1-10
← All annual reports
FY2021 Annual Report · Terns Pharmaceuticals
Sign in to download
Loading PDF…
tern

www.ternplc.com

Tern Annual Report: 2021

TERN_ANNUAL_REPORT_COVER.indd   1-2
TERN_ANNUAL_REPORT_COVER.indd   1-2

17/03/2022   20:06
17/03/2022   20:06

Building Better Businesses“ 2021 has been an 
excellent year  
for Tern and our 
partner businesses”

Al Sisto, CEO

£32.4m

Net assets
2020: £24m

£4.6m

Profit after tax
2020: £0.8m

9.2p

Net asset value (NAV) per share
2020: 7.3p

£2.5m

Funds reinvested
2020: £2m

47%

Network of companies revenue growth
2020: 18%

1.35p

Basic Earnings per share
2020: 0.30p

132

Network of companies employee nos.
2020: 106

A successful year with improved results 
delivered across all financial indicators

Net asset growth of 35% and a 26% 
increase in net asset per share 

Profit before tax increased by 25%

Basic earnings per share (EPS) increased 
by 350% in 2021 and the Company reported 
positive retained reserves for the  
first time

Our network of companies1 delivered 
aggregate year-over-year revenue growth 
of 47% (2020: 18%)

Our network of companies increased 
employee numbers in aggregate by 35%  
to 132 (31 December 2020: 106) and revenue 
per employee increased by 25%.  
(2020: 31% and 24% increases respectively)

Additional capital raised during the year 
of £4m (before expenses) with £2.5m 
of this injected in 2021 into our network 
of companies to support their value 
enhancing fundraises

Wyld Networks value more than doubled 
from £4m at 31 December 2020 to £8.7m 
at 31 December 2021 following a successful 
IPO on the Nasdaq First North Growth 
Market in Stockholm

Further validation of business model 
through a net £6.2m fair value uplift 
across four companies, £4.7m achieved 
for Wyld Networks, and the remainder 
from Device Authority, Konektio and 
Talking Medicines

www.ternplc.com

1 Our ‘network of companies’ or ‘our companies’: Device Authority Limited, Wyld Networks AB, InVMA Limited (trading as Konektio), FVRVS 
Limited (trading as FundamentalVR) and Talking Medicines Limited, which are companies that Tern has interests in, as further described in the 
section headed The Tern Community and as detailed in note 11.

tern an empowering    and productive year

Adding Value
Chairman’s Statement  

Driven To Disrupt
CEO’s Statement  

p7-8

p9-12

The Tern Community
Our Network of Companies  p13-20

Building The Future
Our Strategy 

p21-22

ESG & Enterprise
Our ESG Commitment  

p23-24

Outpacing KPIs
Financial Review  

p25-26

Thought Leadership
The Tern Board  

p27-28

Director’s Report  

p29-32

Corporate Governance Statement  

p33-36

Business Risks 

Director’s Remuneration 

Auditor’s Report 

Financials 2021 

Notice of 2022 AGM  

p37-40

p41-42

p43-46

p47-68

p69-70

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  6

Chairman’s Statement

Adding expertise  
and value to business

For the year ended 31 December 2021

I believe 2021 was your Company’s most 
successful year to date. Each one of the 
companies in our network has made 
substantial and demonstrable progress 
during the year, despite the continuing 
challenges of the global COVID-19 pandemic, 
both in terms of revenue growth and in value.  

The majority of the companies in our network attracted additional 
support and investment from independent third parties this year after 
they conducted thorough reviews, demonstrating ongoing confidence 
in their business models and future prospects. Third parties, in 
addition to Tern, provided additional resources to accelerate the 
development of new products and expand the base of satisfied users 
which led to increased Monthly Recurring Revenue (MRR).

I would like to take this opportunity to thank Al Sisto and the 
Tern executives for their hard work over the year. It is through their 
extraordinary efforts that we have achieved such excellent results. I 
would also like to note my appreciation for the support of our other 
non-executive director, Alan Howarth, who always adds sound advice 
based on his considerable business and financial experience.

Our philosophy is to add expertise and value to exceptional 
early-stage technology businesses in the key growth areas of Internet 
of Things (IoT), Artificial Intelligence (AI) and Data Science, but 
in doing so we have always made sure that we add much more than 
just money. One of our team serves as a director on the board of each 
of our companies and we strive collectively to actively help each 
company with their strategic challenges, whether it is sourcing key 
management skills, identification of target markets, or establishing 
new key sales offices.

During the COVID-19 pandemic, each of our companies have 
been required to substantially change the way they operate. In many 
cases this has involved staff working remotely and they have been 
forced to make, not only creative use of videoconferencing, but also 
good use of other technology tools to ensure that their teamwork 
remains effective. 

In these circumstances extra efforts have been required to 

ensure that ‘esprit de corps’ attitudes are maintained among 
teams. Fortunately, much technology development can be achieved 
effectively through remote working and productivity has generally 
been maintained.

Tern has also gathered the CEOs all of the companies in our 
network in regular themed joint videoconferencing calls to report 
successes and challenges. As a result, one of our companies frequently 
offers help and support to another, and key lessons are learned and 
shared creating a force multiplier effect. 

We have also established a separate ESG (Environmental, Social, 
and Governance) committee among the companies in our network in 
which each of these businesses can share their plans and collective 
conscientiousness for social and environmental factors. We aim to 
build metrics by which in future our ESG ‘score’ can be measured.
During 2021 we raised £4m in fresh funding which we have 
predominantely utilised to ensure that we continue to support our 
network of companies as they grow. 

In one particular case, one of our companies, Wyld Networks, 
which listed on NASDAQ First North Growth Market in July 2021, 
achieved a market value of over £8m and has become a category 
leader. In another, our most recent addition to our network, Talking 
Medicines, has successfully raised external investment, from a 
leading life science investor to continue its value creation path and 
begin its expansion into the US. 

As someone who has been involved with early-stage technology 

businesses for over 25 years, I feel that Tern, as a public company, 
takes a very honest and straightforward approach to its operations and 
our shareholders are free to buy and sell their shares at any time. But I 
must point out that as as the companies in Tern’s network are all early- 
stage, and although we work hard in conjunction with these companies 
and their leadership teams to create substantial value, we are regulated 
by market dynamics and have relatively little control over when such 
value will be realised. 

In short, a stake in Tern should be seen as an ability to participate 
in the development of attractive businesses, generally not available to 
private investors, whose growth, with our guidance, will provide long-
term capital gains.

It is our job to ensure that we work to achieve the strongest return 
for your investment, and we assure you that we will continue to make 
that our principal goal.

Ian Ritchie 
CBE, FREng, FRSE
Chairman

“ I believe 2021 was 

your Company’s most 
successful year to date”

www.ternplc.co.uk

© Tern PLC: All Rights Reserved 2022  8

CEO’s Statement

Staying disruptive  
during global disruption

For the year ended 31 December 2021

I am pleased to report a record year for Tern, 
delivering growth in all key performance 
areas during a year of significant disruption 
to society, industry and particularly the 
technology sector. In a year when the world 
continued to stay at home the companies 
in Tern’s network adapted to meet their 
customers’ requirements and delivered 
more products and services than ever before. 
Performance by our network of companies 
resulted in an increase in our net assets of 
35%, an increase in net assets per share of 
26% and an increase in basic earnings per 
share of 350%. 

As we adjusted to this ‘new normal’, no one predicted the pandemic’s 
far-reaching economic impact, nor how industry would rapidly adopt 
technology and digital transformation. A vast proportion of these 
transformations were and are being led by the IoT, which has become 
a critical strategic component in developing new innovative digitally 
based solutions and new business opportunities. 

We leveraged these wholesale changes of how businesses now 
need to operate and actively supported directly, and with our network 
of partners, to strengthen our businesses, resulting in uplifts to their 
value and in accelerating their Monthly Recurring Revenue (MRR), 
which we consider to be a key metric in establishing their market 
value in a trade sale or Initial Public Offering (IPO). 

Our record performance and growth in 2021 is a testament to 
our strategy, built on our operational expertise, network of industry 
experts here and in the US, and hands on approach. A strategy that 
has helped our management teams adapt to the changing requirements 
of customers and markets, grow their businesses, secure additional 
third-party support and to make Tern the ‘go to IoT company’ for UK 
start-ups in healthcare and deep tech industrial IoT that are seeking to 
become industry leaders on the global stage.

Strategy Update
Tech M&A surged to a staggering US$1.1 trillion during 2021, an 
increase of 71% compared to 2020 and accounted for 20% of the 
US$5.9 trillion in the year’s global M&A deal value and where 
software deals dominated the 2021 tech M&A landscape1.

We expect the robust pace of deal making to continue in 2022 
and beyond. We expect the tech M&A market to stay competitive in 
2022, as strategic player continue to accelerate expansion through 
transformative M&A and as private equity firms head into the year 

with ample dry powder and hundreds of Special Purpose Acquisition 
Companies (SPACs) seek possible business combination targets.

As a result, the strategy of developing early-stage technology 

companies has changed to reflect the key market drivers of the 
acquirers. Today, all of the companies in our network are on a strong 
path, creating product lines that are unique in their solutions and 
are consistently developing an accelerated repetitive revenue model, 
or MRR to drive their market leadership and value. We believe the 
following to represent the key drivers of value that we work to achieve 
with our network of companies:

 ■ True SaaS (Software as a Service), or SaaS, subscription-

based revenues;

 ■ Demonstrated brand recognition and revenue retention;
 ■ Historical and forward growth that achieves the ‘Rule of 

40’ trade-off between profitability and growth;
 ■ IoT solutions that drive critical business insights  

and action;

 ■ In-house engineering team with strong employee 

retention; and

 ■ IoT solutions that become an integral part of managing 

customers’ businesses 

Hence our  focus on obtaining year over year increases in MRR, 

as well as broader support from additional independent new third 
parties to help support them alongside Tern. 

Additionally, we believe the process to create these great 
businesses requires focus and attention. We expect to continue to 
build a network of companies centred around the key components of 
the IoT ecosystem that are critical to usage in Healthcare (IMoT) and 
Industrial (IIoT) such as:

 ■ Connectivity Services 

— LoRA, Satellite, Connectivity Management

 ■ End to End Security (Security by Design)

—   Device Management, Connectivity Management, Two 

Way Control

 ■ Data Analytics and Visualization 

— Virtual Reality/Augmented Reality, Digital Twins

 ■ Application Enablement

—  Data Curation, Artificial Intelligence, Machine Learning 

Leading to Insights

With Tern’s collective expertise and our hands on approach 
this enables us to deliver, where helpful, the advice and support 

“ We strongly believe  
that values and culture  
are just as important  
as strategy”

In the ongoing challenges that have come from the pandemic, 
Tern succeded in delivering strong results and rewards to 
shareholders, while helping its network of companies not 
only navigate difficult times, but to actively strengthen and 
expand their commercial reach and opportunities.

www.ternplc.co.uk

1. Refinitiv Reports 2021 Q4 – Global M&A Financial Advisors

© Tern PLC: All Rights Reserved 2022  10

 
 
 
 
CEO’s Statement

our companies need to assist them to achieve their strategic and 
operational goals, whilst not diluting our efforts across an overly 
broad set of generalist businesses. We work to provide founders with 
the tools we wished we had when we were in their shoes.

As a group of former founders and operators we focus our help 

across our companies specifically in four key areas:

 ■ use of capital; 
 ■ revenue and go-to market;
 ■ product; and  
 ■ talent. 

As  mentors and advisors, we relentlessly hustle to deliver value in 
these four areas. We give our time liberally, listen intently, and take  
action immediately. We have travelled this road many times and have 
a deep understanding of the challenges facing founders. Winning is a 
mindset. We are as ambitious as our founders and know that winning 
requires passion, grit, and both dynamic and orthogonal thinking 
that we can deliver from our diverse expertise, broad networks and 
experience. Our common thread is supporting disruptive companies 
and teams with strong products in large markets where we can help 
accelerate their brand recognition and MRR growth and path to 
success quickly.

Our Values and Culture
We strongly believe that values and culture are just as important as 
strategy. We seek to partner with ambitious entrepreneurs who want 
to tackle big, hard problems in ways most think not possible to create 
a better future. In this regard, we believe that integrity, transparency, 
humility, and a commitment to excellence are paramount to our 
mutual success. Those values underpin a culture that is team-first, 
non-hierarchical and meritocratic.

Operations and Financial Performance
Tern’s collective operating experience in SaaS Software, Deep Tech, 
and Healthcare IoT technologies has helped each of the companies in 
our network to make substantial progress during 2021, which I believe 
has significantly increased the value that will ultimately be delivered 
for Tern shareholders. Value that can be measured in accelerated 
commercial progress, a continued increase in year-over-year MRR 
and the willingness of third-party partners to join us on  
the journey.

We achieved this key operating improvement by working side by 
side with the companies in our network through the global economic 
paralysis in the early days of the COIVD-19 pandemic to adjust to the 
new normal, resulting in renewed and enhanced commercial traction 
and growth.

Keeping a careful eye on our companies’ liquidity and their access 

to additional resources when needed, were and are, we believe, the 
imperative to preserving shareholder value during economic shocks, 
such as our most recent experience caused by the global pandemic. 
We are vigilant and continue to be relentless with our support and 
are continuously working to create pathways towards sustainable 
multi-year growth that is several multiples over what has already 
been achieved. I am pleased to say that with the support of our 
shareholders, Tern was able to support our companies with additional 
resources, as required, during these times. In addition, to leverage the 
synergies of our network of IoT focused companies, we continued our 
series of fortnightly CEO round tables discussing the topics relevant 
to growing disruptive businesses and how to maximise value creation 

www.ternplc.com

in the businesses, for example, by sharing go-to-market strategies and 
technologic advancements.

Three successful 2021 examples of the value created for our 
shareholders resulting from our vigilance and hands-on approach are 
Wyld Networks, InVMA (trading as Konektio) and Device Authority. 
Today, Wyld Networks is a virtual satellite network operator that 

develops and delivers innovative wireless technology solutions that 
enable affordable connectivity for IoT devices and sensors anywhere 
in the world, especially for the 85% of the world’s surface where 
there are no traditional cellular networks. Starting from humble 
beginnings in Brighton and Cambridge, we saw, in the two founders’ 
ideas and passion, the ability to disrupt access to the Internet. 
Securing new commercial partners and helping to form the creation 
of a global IoT consortium, they have engaged customers to create 
a new market segment with launch partner agreements with end-
users in energy and agriculture with customers such as Chevron and 
Bayer. Their relevance is also validated by their consortium partners 
which include some of the world’s largest terrestrial LoRaWAN® IoT 
operators such as American Tower and Senet, with an objective to 
offer their existing and new customers the Wyld Connect satellite IoT 
solution to provision for 100% global coverage. Strong performance 
by the company has validated our approach and has created value for  
our shareholders. 

Similarly at Konektio we, in collaboration with the founders, saw 

the opportunity to synthesise years of experience in designing and 
creating control systems as an engineering services business into 
a remote sensor/device monitoring SaaS based application which 
is now in the market as AssetMinder®. It is a product that connects 
legacy and existing systems and IoT based sensors to provide 
contactless data driven insight into their performance and state  
of operation. 

Our commitment to supporting Konektio’s transformation from 
a services business to a SaaS software company using AssetMinder® 
as the catalyst is another proof point in how our network of resources 
help founders create new and exciting business models that solve 
critical problems in large global markets. Business models that 
accelerate value creation through an MRR based metric and that 
attract additional partners to help us continue the journey in making 
AssetMinder® an industry leading product.

Lastly, and of significant importance was Device Authority’s 

strategic partnership transaction with Venafi, a US$1.15 billion 
market cap industry leader, announced on 2 December 2021. This 
was the fulfilment of a commitment we made previously. We believe 
obtaining an active strategic partner with solid cybersecurity 
credentials and a large presence in the United States will help 
catapult Device Authority into North America. Venafi, with its major 
investor Thoma Bravo, fulfils this goal. However, in crafting this 
strategic transaction we did not lose sight of our ultimate objective to 
continue to create and return value to our shareholders.

Helping to build a company creating sustainable value is a 
journey that demands courage to take difficult and sometimes 
complicated actions to help put our companies on a proper trajectory 
for growth that is the critical component to drive value creation for 
our shareholders. Our network of companies are now well-funded 
and in the best commercial shape since our inception. The Tern team 
is fully focused on delivering another year of successful progress. We 
are constantly focused on building our companies to their next stage 
to maximise the opportunities available in the IoT market.

I fundamentally believe that our network of companies have very 

exciting futures ahead of them and 2022 will be a year of further 
significant progress.

“Our network of  
companies are  
well-funded and in the best  
commercial shape  
“
since our inception

Sustainability and Governance
The excellent performance and results by the Company in 2021 are 
testament to the collective efforts of not just the Board, but of every 
employee at Tern and at our network of companies.

Since our humble beginnings in 2013, Tern has worked from a 
foundation built upon a strong corporate ethic in all its dealings and 
always strives to act in the best interests of its stakeholders. Proactive 
engagement with all stakeholder groups remains fundamentally 
important to our Board. We are members of the Quoted Companies 
Alliance (QCA) and have adopted their code of conduct and 
recommendations for industry best practices as part of our operating 
culture. For example, whilst the COVID-19 lockdowns and remote 
working imperatives curtailed face-to-face engagement during the 
past two years, Tern has been proactive using digital technologies 
to communicate such as podcasts, blogs and online Capital Markets 
Day events. 

During the year we established an Environmental, Social and 

Governance (ESG) committee comprised of highly motivated 
employees from the companies in our network as many of these 
companies are developing technologies which help society, improve 
the quality of life, and ultimately help reduce carbon emissions. To 
ensure a unified mission, the ESG Committee is led by Alan Howarth 
and supported by Sarah Payne, our CFO. Leveraging Sarah’s passion 
for ESG, and the committee’s broad levels of expertise from the 
participants, we are now identifying key metrics to allow our network 
of companies to contribute positively to society’s needs, minimising 
their carbon footprint, driven by good business sense and strong 
governance. The committee is also chartered to provide Tern with an 
ESG checklist for consideration in all new company building activity.

We look forward to reporting further on the committee’s activities 

during the year and its work towards making Tern and its network 
of companies’ leaders in ESG practices for the mutual benefit of all 
stakeholders and the planet as we strive to become carbon neutral  
in 2022.

Outlook and Summary

Our record financial results succinctly reflect the quality of the 
business which we have transformed by using the expertise of our 
team and network of resources. We greatly appreciate the continuing 
inspiration and support of our shareholders and advisers and are 
pleased to be delivering on our Key Performance Indicators (KPIs) 
and independent third-party validation of value creation throughout 
our companies.

Digital Transformation is leading the way in the markets we target 

and helping to create a new economic normality. We believe this 
heightened interest in using IoT devices, both new and installed, will 
accelerate during 2022. Acceleration that will bolster aggregate MRR 
growth across our companies now and for the foreseeable future. 
2021 was a very good year with new independent third-party partners 
brought into our companies and we expect the continued MRR growth 
to drive additional strategic interest this year to help solidify their 
market segment leadership. 

Having received new capital to fund their disruptive ambitions, we 

believe we will see significant further growth in employment across 
the companies in our network to aid in the execution of our plans  
to expand.

As we are continually evaluating the possibilities for our network 

of companies, we are also continuously evaluating additions and or 
replacements to support the growth of Tern and to stimulate additional 
value creation for our shareholders. We expect the Tern team to 
review additional opportunities to expand our network of companies 
during this year with an objective of securing an interest in at least 
one new exciting company to be added to the network that will add 
new capabilities, talent and the opportunity to support our growth 
objectives and improve our results.

Tern has grown significantly since its modest inception in 2013 

via a combination of organic initiatives and shareholder support. We 
anticipate that this combined approach will continue during the next 
three years along with non-organic initiatives to continue increasing 
the total value of our business and the holdings of our shareholders.  
The successful execution of Tern’s strategy by our team, despite the 
uncertainties created by the pandemic and government responses, has 
materially grown shareholder value and is a proof point that the Tern 
hands-on model works.

As CEO, I am extremely proud to be part of Team Tern and its 
culture, which is comprised of outstanding people who care about 
each other, our companies, our stakeholders and, importantly, who 
care about our planet.

I look forward to updating you, our shareholders throughout 
the year to report on our execution, growing confidence, expanding 
ambition, and value creation.

Albert Sisto
CEO

© Tern PLC: All Rights Reserved 2022  12

Device Authority

Device Authority Limited (“DA” or “Device Authority”)
Holding: 53.8%

The Tern  
Community

Tern is committed to working with companies that are building the 
businesses who will change the future for the better.

www.ternplc.co.uk

Device Authority is a global leader in Identity 
and Access Management (IAM) for the IoT; 
focused on the automotive, medical device 
(IoMT) and industrial (IIoT) sectors.

Device Authority’s KeyScaler™ platform provides zero touch 
provisioning and complete automated lifecycle management for 
securing IoT devices and data at scale, with frictionless deployment 
across device provisioning, authentication, credential management, 
policy based end-to-end data security/encryption and secure OTA 
(Over the Air) and HSM (Hardware Security Module) updates. 
KeyScalerTM is system agnostic, and protects their customers’ 
global IoT deployments at the edge, in the cloud and integrating into 
complex policy-driven requirements, independent of the customers’ 
proprietary hardware and software environments. KeyScalerTM is 
deployed both direct, and through key platform and system integrator 
partners such as Microsoft, Wipro, EPS Global/Intrinsic ID.

“We’ve been working with Tern since we  
started, and they’ve not only helped us in 
advancing our technology, but also helped us 
gain access to the markets which are key to our 
continued commercial success”

Darron Antill, CEO

© Tern PLC: All Rights Reserved 2022  14

Konektio

InVMA Limited (“Konektio”)
Holding: 36.8%

FundamentalVR

FVRVS Limited (“FundamentalVR”)
Holding: 26.9%, plus convertible  
loan of £530,000

Konektio is pioneering the next 
generation of Industrial IoT, 
delivering value by connecting 
businesses’ people, process, 
places and things.

Konektio helps industrial and manufacturing companies prosper by 
converging their physical assets with new transformational digital 
insights. Konektio’s AssetMinder® is a modular, industry 4.0, IoT 
SaaS platform, using a wide range of analytical tools and AI and 
machine learning algorithms to connect up whole factory floors and 
processes as well as managing resources into and out of the factory. 
AssetMinder® assesses the effectiveness and efficiencies of entire 
operations, putting customers in control of their assets and therefore 
directly impacting productivity, efficiency and business outcomes.

Providing a solution that is revolutionising 
Life Science companies’ approach 
to surgery practice and education, 
FundamentalVR is making huge strides in 
its markets in Europe and the US.

FundamentalVR provides the Company with exposure to the rapidly growing medical 
simulation market using low cost open-system IoT devices. Their proprietary HapticVRTM 
platform replaces wet labs and cadaveric training with remote, collaborative training to 
accelerate life science product adoption.

“ We’re so excited about the next  
developments of our AssetMinder ®
  tool,  
we can’t bring them online fast enough. 
We think our future is bright with the 
support of Tern”

Peter Stephens, CEO

“ Tern brought a wealth of experience in how to build a 
business, and for the last few years we’ve been doing 
exactly that, growing from where we were as a company 
of just three people, to where we are today”

Richard Vincent, CEO

© Tern PLC: All Rights Reserved 2022  16

www.ternplc.com

Talking Medicines

Talking Medicines Limited (“Talking Medicines”)
Holding: 23.4%

Wyld Networks

Wyld Networks AB (publ) (“Wyld Networks” or “Wyld”)
Holding: 58.7%

WYLD NETWORKS

Talking Medicines continue on their 
mission to become the gold standard in 
patient intelligence by medicine.

Talking Medicines is a social intelligence company designed specifically for the 
pharmaceutical industry. By structuring and translating the patient’s voice on social media 
into actionable intelligence, it focuses on assisting pharmaceutical companies in delivering a 
greater return on investment for marketing and delivering better health outcomes for patients. 
Its platform, PatientMetRx, is an artificial intelligence (AI) and natural language processing 
(NLP) powered social intelligence service, to provide pharmaceutical companies with insights 
on patient experience on a scale and depth not previously possible.

“ Tern is a very different type of partner, they are with 
you for the long-term and are a real team player as 
you build your business”

Jo Halliday, CEO

Wyld’s ongoing success 
has meant more and more 
customers signing up to  
their low-cost, high value  
data solution.

Wyld Networks mission is to develop and market innovative solutions 
to create global and affordable wireless connectivity for people and 
things, from connecting IoT devices in hard-to-reach areas with 
satellite IoT solutions to connecting smartphones together in mesh 
networks without the need for WiFi or 4G. 

“ Tern brings a wealth of real-world experience in 

building companies from start-up through to scale-
up. The collaborative nature of the way we all work is 
invaluable in sharing expertise and knowledge that 
helps us all grow as businesses”

Alastair Williamson, CEO

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  18

Push Technology

Push Technology Limited (“Push Technology” or “Push”) 
Holding: < 1%

Looking to accelarate the 
deployment of real-time 
applications, Push is bringing 
client products to market, fast.

Push significantly enhances the ability of organisations to 
communicate in real-time. This includes direct communication 
as well as indirect, for example, by refreshing data displayed 
information in real-time rather than when a user explicitly asks for 
an update. Interactive applications are infinitely more engaging, 
updating in real-time as new data becomes available.

www.ternplc.com

“We are thrilled to be an active  
partner with companies that are 
looking to deliver real change 
through technology”

Al Sisto, CEO

© Tern PLC: All Rights Reserved 2022  20

The Strategy

“ Building the next generation of 

solutions that will help accelerate 
transformation, security and 
sustainability in 2022 and beyond”

Tern is a company focusing on large global 
markets that are being disrupted by digital 
business value needs.  Market issues 
that require new thinking and expertise 
to solve the issues created by the digital 
transformation of their existing processes. 

It’s a strategy that has teamed us with visionary businesses and business 
leaders, that are seeking to shake up the status  
quo — solving real problems for industries that until now seemed 
impossible on a global scale — and Tern is as driven as  
these entrepreneurs are, to use technology to deliver process, social and 
cultural change, alongside creating significant commercial success. 

We have, and will continue to actively seek out companies at crucial 

stages of their development — often early in their first rapid expansion 
phase, bringing our wealth of market knowledge and business building 
expertise to the table at this critical time to maximise the impact on the 
business and set the stage for rapid growth. 

Based on identifying a clear path to market, coupled with a clearly 
identified customer value programme, Tern acts as an active strategic 
advisor, providing structured, regular mentoring sessions based on our 

experience and what each unique business requires. We bring a very 
operational “hands-on” approach combined with board level experience 
to strategically guide businesses through the minefield of bringing 
innovation to the market at speed and scale, successfully.

A critical benefit Tern offers is the synergies within the core 
technologies of our network of companies which creates a “network 
effect” of collaboration. Our partnership businesses do not exist in 
silos, they are part of a thriving collaborative network of like-minded 
businesses, that proactively share experiences, insights and information 
to the benefit of all. 

Tern believes technology is the huge driver for commercial 
success and societal change when directed and focused properly. Our 
support and assistance for our network of companies does not stop at 
growth and commercial success but to also help them realise their true 
corporate responsibility across every aspect of their operations. So, 
ESG is not simply a tick-box, but a core part of each company’s DNA. 
2021 was a hugely successful year, and we intend to expand Tern’s 

strategic impact to transforming businesses. 

As the world emerges from recent challenging events, Tern will 

expand on this success and expertise to continue building the next 
generation of solutions that will help accelerate transformation, 
security, and sustainability in 2022 and beyond.

Targeting markets with proven value

Industrial IoT Market worth $106.1 billion by 2026, at a CAGR1 of 6.7%2

Smart Factory Market worth $134.9 billion by 2026, at a CAGR of 11.0%3

Internet of things (IoT) in Healthcare Market Worth USD 446.52 Billion at 25.9% CAGR by 20284

1 Compound annual growth rate
2 Markets and Markets, Industrial IoT Market, 2021
3 Markets and Markets, Smart Factory Market with COVID-19 Impact, 2021
4 Fortune Business Insights, 2021

Building  
the businesses  
of the future

Tern’s commitment to its network of companies is driving 
their competitiveness and commercial success.

”

p act

“T er n is  w orkin g 
to e n s ure th at all 
of its n et w ork of 
p a nies h ave a 
p o sitive E S G i m

c o m

Enterprise  
and ESG

Our ESG Commitment

2021 saw strong progress on integrating 
ESG throughout our Company. We set out 
to establish core ESG principles during 
this year. This has included:

Established an ESG committee with representatives from the 
Board and all our companies meeting regularly throughout  
the year.

Establish route to becoming carbon neutral in 2022. Assessment 
of carbon footprint started and plan to fully offset carbon 
emissions during 2022. Continue to act on this to drive a 
meaningful reduction each year.

Updated our code of conduct to reflect ESG at the heart  
of what we do, explaining how we do business ethically  
and responsibly. 

Provided diversity & inclusion training to senior executives at 
our companies.

Actively encouraged the sharing of great ESG ideas and  
initiatives across our companies

Continuing to maintain high standards of governance for  
all our companies

Our strategy ensures we only back companies that have a 
positive ESG impact: the real-time insights driven from IoT make 
our communities safer and more connected, and industry more 
efficient and productive

Tern:  
building better futures 

© Tern PLC: All Rights Reserved 2022  24

Financial Review

Outpacing our own KPIs 

For the year ended 31 December 2021

2021 was a successful year of growth, 
measured by an improvement across all 
Tern’s KPIs. Following 2020, when attention 
was rightly focused on ensuring all of our 
network of companies protected their 
position at a time of extreme uncertainty, 2021 
marked a period of growth and progress for 
these companies.

As a Company we continued to focus on providing shareholders with 
access to some of the best private Internet of Things (IoT) technology 
focused companies in the UK.
During the year, one of these companies successfully listed on the 
Nasdaq First North Growth Market, while another two successfully 
completed value enhancing fundraises with well-respected partners. 

We further strengthened our balance sheet by raising new equity 

capital of £4m in July 2021. This enabled the Company to continue 
to support our network of companies as they focus on developing 
and growing their Monthly Recurring Revenue (MRR). 

The value of interests in our network of companies has increased 

by 40% from £21.9m as at 31 December 2020 to £30.6m as at 31 
December 2021. The valuation includes additional funding of 
£2.5m, including alongside new syndicated partners at Device 
Authority and Konektio and fair value growth of £6.2m. This 
primarily comprises a £4.5m fair value gain for Wyld Networks and 
an aggregated £1.7m gain across Device Authority, Konektio and 
Talking Medicines. 

Net assets increased by 35% to £32.4m as at 31 December 2021 
(31 December 2020: £24.0m) and included a strong cash balance of 
£2.0m (31 December 2019: £2.1m). There is no debt on the balance 
sheet.

During the year, £1.5m of cash was used in company operations, 

£2.5m deployed in the existing network of companies and a net 
£3.8m raised through the July 2021 equity fundraising.

Income Statement and Statement of 
Comprehensive Income

The Company does not charge high board fees to ensure 
capital is not deducted at source and is instead reinvested in 
the companies in our network to drive value creation. Total 
investment income increased to £6.1m, a £4m increase compared 
to 2020. This has been driven primarily by the fair value uplift 
for Wyld Networks as well as fair value uplifts across three of the 
five other companies.

Overheads overall were fairly stable at £1.7m in 2021 (2020: 
£1.5m). This consisted of administration costs of £1.6m and other 
expenses of £0.1m. The administration costs included a £0.1m 
increase in directors’ fees compared to 2020 which included 
small increases in salary and benefits as well as the return to full 
salary following the six-month reduction in fees in 2020 due to 
COVID-19 related management of uncertainty. Other expenses 
include costs relating to a share-based payment charge for options 
issued in 2019 and 2020 and recharged legal costs to the 
companies in our network.

Events after the end of the reporting period 
impacting 2021 results
On 1 February 2022, it was announced that Talking Medicines 
had completed a £1.59m fundraise at an increased valuation. The 
Company’s investment in Talking Medicines is now valued at  
£1.79m, which included an additional investment of £0.4m by Tern  
in this round. This valuation was taken into account in the 2021 
valuation of Talking Medicines.

Key performance indicators
The Company’s financial Key Performance Indicators (KPIs) are 
focused on increasing net asset value, increasing net asset value 
per share and delivering consistent turnover growth from our 
network of companies. The Company also monitors non-financial 
KPIs, the primary focus being on the increase in employee 
numbers and turnover per employee at our network of companies 
which is an indicator of growth to support commercial success. 
These indicators are monitored closely by the Board and the 
details of performance against these are given below.

The return on investments: 

Unrealised fair value:

 ■ Wyld Networks Limited: £8.7m valuation (31 December 
2020: £4.0m): The equity valuation has increased due to 
additional funding provided to the company and a fair value 
uplift based on the market capitalisation as at 31 December 
2021; 

 ■ Device Authority: £14.7m valuation (31 December 2020: 
£12.8m): The valuation has increased due to additional 
funding provided to the company and a fair value uplift 
based on the recent strategic equity fundraise in December 
2021;

 ■ Konektio: £2.2m valuation (31 December 2020: £1.2m): The 
equity value of Konektio increased due to additional funding 
provided to the company and a fair value uplift based on the 
recent equity fundraise in December 2021;

 ■ FundamentalVR: £3.6m valuation (31 December 2020: 

£3m): The valuation has increased due to additional funding 
provided to the company via a convertible loan note. 
The equity value remains unchanged and is held at fair 
value, taking into consideration the current and expected 
performance of the company. As part of the valuation in the 
current year, the directors have not considered it necessary to 
recognise a fair value movement (from the most recent third-
party valuation performed in October 2019); 

 ■ Talking Medicines: £1.4m valuation (31 December 2020: 
£0.9m): The investment is held at fair value with the most 
recent equity fundraise in January 2022 taken into account. 
The additional investment in January 2022 is not included in 
the 2021 results; and

 ■ Push Technology: £0.02m valuation (31 December 2020: 

£0.03m): The investment is valued at fair value with the price 
of the most recent valuation taken into account.

The companies in our network are early-stage businesses in evolving 
markets where there is a lack of comparative businesses available on which 
to provide a comparable valuation and therefore value has been based on 
an assessment of numerous factors which includes the multiples achieved 
in comparable markets on recent transactions, and an assessment by the 
Board on the strength of our companies sales pipelines and achievability 
of their 2022 sales forecast. Wyld Networks is measured as a Level 1 
company under IFRS and as such the value is determined by reference to 
the appropriate quoted market price at the reporting date.

The net assets of the Company at 31 December 2021 showed strong 
growth to £32.4m (2020: £24.0m). The net asset value per ordinary share 
as at 31 December 2021 also increased to 9.2p  
(2020: 7.3p).

The year-over-year growth in the aggregate revenue of our network of 

companies increased by 47% from 2020 to 2021  
(18% from 2020 to 2021) which provides an indication of growth  
in the overall portfolio.

The Company has non-financial KPIs which are also monitored 
regularly by the Board. The non-financial KPIs are focused around the 
growth in employee numbers in our network of companies. We believe 
these factors help serve as leading indicators of the future performance 
and our impact on our stakeholders:

Employees in our network of companies increased by 35% from 
2020 to 2021 (0% from 2019 to 2020), and this increase was balanced by 
an associated increase in revenues such that revenue per employee also 
increased by 25% from 2020 to 2021.

Sarah Payne
CFO

Sarah Payne, CFO 

“ 2021 was a 
successful 
year of growth, 
measured by an 
improvement 
across all KPIs”

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  26

 Tern:  
  True thought leadership

Experience and passion drive the board to help companies build busineses that deliver 
sustainable success as true partners

The Tern Board

Ian Ritchie 
Chairman

Albert Sisto
Chief Executive Officer

Sarah Payne
Chief Financial Officer

Ian was appointed as Chairman of the Company in 
June 2017. Ian is also the non-executive Chairman 
of Computer Applications Service and Krotos and 
completed his term of office as the Chairman of 
iomart plc in 2018. He has also been involved with 
technology risk finance for over 25 years.

He founded OWL in 1984, which pioneered 
hypertext application development (a forerunner 
to the world wide web) selling the company 
to Panasonic in 1989. Since then, he has been 
personally involved in over 50 start-up high-tech 
businesses. Ian is a Fellow of the Royal Academy of 
Engineering, the Royal Society of Edinburgh, and 
a Fellow and past President of the British Computer 
Society. His TED talk has been viewed over 
650,000 times.

Committee membership: 

Member of Audit Committee and  

Remuneration Committee

Albert is one of the original founders of the 
Company and was appointed as CEO in September 
2016. He chairs the Investment Committee and also 
acts as non-executive Chairman and non-executive 
director for selected investee companies. Albert is 
a technology industry veteran with more than 25 
years of senior executive level experience. 

As Chief Operating Officer at RSA Data Security 
Inc, the leading security software company, he led 
its transformation from a passive patent licensing 
operation to an aggressive, sales-oriented software 
company. At RSA he negotiated partnership 
agreements with IBM, Intel, Compaq, Cisco  
and Nortel. 

Albert was Chairman, President and CEO of 
Phoenix Technologies Limited, the global BIOS 
software company (NASDQ:PTEC) and Chairman 
and CEO of HiFn (NASDAQ:HIFN). He also served 
as a Venture Partner for Nauta Capital designer 
Transmeta and was involved in spinning off  
Silicon Corporation.

Sarah was appointed to the Board in September 
2015 and is responsible for the Company’s financial 
and compliance functions as well as being a 
member of the Investment Committee and acting  
as a non-executive director for selected  
investee companies. 

Sarah qualified with Ernst & Young as a Chartered 
Accountant and spent six years with the firm, 
joining its corporate finance team for the later years 
and is now an FCA. She spent six years with the 
BBC, firstly within their corporate commercial 
and investment strategy team and then as Head 
of Financial Planning and Analysis. For the 
seven years before joining Tern Plc, Sarah was an 
outsourced Finance Director for SME businesses 
principally within high-tech markets. 

Bruce Leith
Business Development Director

Matthew Scherba 
Investment Director

Alan Howarth
Non-Executive Director

Bruce was one of the original founders of the 
Company with Albert in 2013. He is a member of 
the Investment Committee and a non-executive 
director for selected investee companies. Bruce 
began his career with IBM and has extensive 
international sales management and board level 
experience in the software industry including senior 
level positions at DataWorks Corporation, London 
Bridge Software International and Codestream. 

Specialising in delivering high-growth, high profit 
results through product development, portfolio 
repositioning and geographical expansion, Bruce 
was involved in the successful sales of a number 
of companies including Interactive UK, London 
Bridge and Codestream. Bruce is also an active 
angel investor in several high growth  
software businesses.

Matthew joined the Board in March 2020 and is 
a member of the Investment Committee and a 
non-executive director and Chairman for selected 
investee companies. He has over 25 years of 
international executive management experience 
covering the full technology lifecycle, focused on 
strategy and commercial development, including 
investment and NED roles. 

He is a life-long entrepreneur with experience 
creating, building and scaling early-stage 
technology businesses. He has founded, run and 
invested in early-stage companies across the 
Internet of Things (IoT), including software, 
hardware, mobile, Artificial Inteligence (AI), 
machine learning, and blockchain.

Alan was appointed to the Board in November 2015 
and acts as a non-executive director for FVRVS, 
one of the Company’s investee companies. Alan 
has extensive experience as a Chairman and non-
executive director of private and public companies. 
He is a specialist in building and selling technology 
businesses. Previously, Alan was a partner at Ernst 
& Young and is one of the founding partners of the 
EY Management Consulting practice in the UK. 
For the last eighteen years he has been managing a 
portfolio of non-executive appointments.

Committee membership:  

Chair of Audit Committee and Chair of 

Remuneration Committee

© Tern PLC: All Rights Reserved 2022  28

 
Director’s Report

Big challenges,  
big opportunities

For the year ended 31 December 2021

The Company is registered as a public limited company (plc). The 
Company’s Ordinary shares of 0.02p each are traded on AIM of the 
London Stock Exchange.

Principal activities
The principal activity of the Company is investing in the Internet of 
Things sector.

Results and dividends
The results for the year are shown in the Income Statement and 
Statement of Comprehensive Income on page 48.
The profit for the year was £4,578,321 (2020: £803,891). 
The directors do not recommend payment of a dividend.

Political and charitable contributions
Recognising the ongoing difficulties suffered by many in our local 
communities due to the pandemic, the Board approved a £10,000 
charitable donation to a number of charities nominated by the 
employees and directors, all of which support vulnerable children  
and adults living in poverty or homelessness around the UK  
(2020: £10,000).

Control procedures
Operational procedures have been developed for the Company that 
embody key controls over relevant areas. The implications of changes 
in law and regulations are considered by the Company.
The Board considered the need for an internal audit function and 
during 2021 an internal audit function was set up to undertake control 
reviews of our network of companies, under the direction of the CFO.

COVID-19
The developing COVID-19 pandemic understandably influenced 
the Board and its Committee’s activities in the early part of the 
year. As the year progressed, the Board’s focus, outside its usual 
responsibilities, turned to ensuring the Company operated as usual 
with a mix of face to face and hybrid interactions, with consideration 
given to how best to ensure good interaction with stakeholders.   
The fortnightly video conference with our network of companies’ 
CEOs continued but with a more strategic focus and encouraged the 
interaction of all attendees on a wide range of value creation, people 
and ESG topics. 

Even during a time when restrictions of movement are still a 
possibility, the team and our network of companies are in a good 
position to continue to grow, capitalising on the successes of the year, 
whilst remaining flexible, agile businesses; essential in the changeable 
political and healthcare environment we currently face.

Going concern
The financial statements have been prepared on the going concern 
basis because, as set out in detail in Note 1.3, the directors have a 
reasonable expectation that the Company has adequate resources 
to continue in operational existence for the foreseeable future. 
This has been assessed using detailed cash flow analysis so that the 
Board can conclude that the Company has sufficient working capital 
resources to continue for at least 12 months without any additional 
financing requirements. The ongoing impact of COVID-19 has been 
considered as part of this assessment. In the event that opportunities 
are presented such that additional funding was required, management 
are confident that they would be able to obtain additional funds from 
various sources.

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  30

Director’s Report

Directors and directors’ interests
The directors who held office during the year and their interests in the 
Ordinary shares of the Company are as follows:

Ordinary shares at:  

31/12/2021 

31/12/2020

Alan Howarth  

- 

-

Bruce Leith 

8,857,233 

8,857,233

Sarah Payne 

100,000 

100,000

Ian Ritchie 

1,010,333 

1,010,333

Matthew Scherba 

716,666 

716,666

Albert Sisto 

10,416,666 

10,416,666

Options granted to the directors by the Company are disclosed under 
the “Report on Directors Remuneration”.

Significant shareholdings
As at 16 March 2022, the company had been notified of the following 
shareholdings of 3% or more of the share capital.

Number of 
Ordinary 
Shares 

Percentage of
Issued Shares
Held

Albert Sisto 

10,416,666 

3.0%

Statement of Directors’ responsibilities
The directors are responsible for preparing the Strategic Report, 
Directors’ Reports and the financial statements in accordance with 
applicable law and regulations.

Company law requires the directors to prepare financial 

statements for each financial period. Under that law, the directors have 
elected to prepare the Company financial statements in accordance 
with UK-adopted international accounting standards. Under company 
law, the directors must not approve the financial statements unless 
they are satisfied that they give a true and fair view of the state of 
affairs of the Company and of the profit or loss of the Company for 
that period. 

In preparing those financial statements, the directors are  
required to:

 ■ select suitable accounting policies and then apply  

them consistently;

 ■ make judgements and accounting estimates that are 

reasonable and prudent;

 ■ state whether international accounting standards have been 
followed subject to any material departures disclosed and 
explained in the financial statements; and statements; and

 ■ prepare the financial statments on the going concern 
basis unless it is inappropriate to presume that the 
Company will continue in business.

www.ternplc.com

The directors are responsible for keeping adequate accounting records 
that are sufficient to show and explain the Company’s transactions and 
disclose with reasonable accuracy at any time the financial position of 
the Company and enable them to ensure that the financial statements 
comply with the Companies Act 2006. They are also responsible 
for safeguarding the assets of the Company and hence for taking 
reasonable steps for the prevention and detection of fraud and other 
irregularities. 

The directors are also responsible for ensuring that they meet their 
responsibilities under the AIM rules format. 

The directors are responsible for the maintenance and integrity of 
the corporate and financial information included on the Comany’s 
website. Legislation in the United Kingdom governing the preparation 
and dissemination of financial statements may differ from legislation 
in other juristiction.

Section 172 compliance
Section 172 of the Companies Act 2006 format imposes a general duty 
on every director to act in a way they consider, in good faith, would 
be most likely to promote the success of the company for the benefit of 
its members (shareholders) as a whole. When considering what is most 
likely to promote the success of the company, directors must have 
regard to various matters designed to ensure that boards consider the 
broader implications of their decisions, not just for their shareholders 
but for a wider group of stakeholders. These matters include:

 ■ the likely consequences of any decision in the long term;
 ■ the interests of the company’s employees;
 ■ the need to foster the company’s business relationships 

with suppliers, customers and others;

 ■ the need to maintain an effective company selection 
process, including maintaining a strong pipeline of 
opportunities and a thorough due diligence process;

 ■ the impact of the company’s operations on the community 

and the environment;

 ■ the desirability of the company to maintain a reputation 

for high standards of business conduct; and
 ■ the need to act fairly as between members of the 

company.

 During the year, the Board considered the impact of COVID-19 on 
its stakeholders and continued to take appropriate action to ensure the 
mitigation of any impact on the Company. The Board also continued 
the round table meetings with our network of companies’ CEOs to 
provide both a support network and a forum for strategic discussion, 
encouraging the continuing exploitation of synergies that are already 
inherent in the underlying businesses. 

The Board determines the strategic objectives and policies of the 
Company to best support the delivery of long-term value, providing 
overall strategic direction within an appropriate framework of 
rewards, incentives and controls. The Board is collectively responsible 
for the success of the Company: the executive directors are directly 
responsible for running the business operations; and the non-executive 
directors are responsible for bringing independent judgement and 
scrutiny to decisions taken by the Board. The non-executive directors 

Key board decisions

Stakeholder considerations

The Board considered and approved 
a private placing and retail offer via 
PrimaryBid to raise in total gross proceeds 
of £4m.

The Board considered the ability of the Company to partner with new businesses and 
continue backing our existing companies, supporting long-term sustainable growth of  
the business.

Consideration was also given to the increased involvement of PrimaryBid to ensure 
shareholders were given the opportunity to participate in this fundraise.

The Board considered and approved a 
further $1.25m of funding into Device 
Authority alongside a new investor,  
Venafi Inc. 

Consideration was given to the valuation placed on the business and the strategic value of 
an industry partner joining the Device Authority board.

Consideration was given to how the strategic value of this fundraise should be 
communicated to all stakeholders to explain the value created by the maturing of the 
partnership between Device Authority and Venafi.

The Board considered and agreed that 
regular presentation with CEOs should  
be held during the year. 

Following the success of the November 2020 online shareholder presentation the Board 
agreed that regular presentations involving companies’ CEOs should be planned to ensure 
stakeholders heard from each of the companies during the year and had the opportunity to 
pose questions.

The Board also requested increased visibility of shareholder questions and concerns 
following the Board evaluation process. A standing item was already included on the Board 
agenda and a formal feedback report is now also provided for every Board meeting.

The Board considered the resolutions that 
did not pass at the AGM and adjusted the 
details of the resolution being put forward 
for approval as a result.

The Board requested detailed feedback on shareholder sentiment following the AGM. The 
Board considered how to reflect this feedback in an adjusted resolution which was then put 
to the general meeting and passed.

must satisfy themselves on the integrity of financial information and 
that financial controls and systems of risk management are robust. 
Following presentations by the executive directors and a disciplined 
process of review and challenge by the Board, clear decisions on 
policy or strategy are adopted, and the executive directors are fully 
empowered to implement those decisions. Examples of stakeholder 
considerations in certain key Board decisions during the year are 
provided in the above table.

Stakeholder interests and the matters listed above are factored into 

all Board discussions and decisions. A more detailed assessment of 
stakeholder engagement is included in the Corporate Governance and 
Compliance section on pages 33-36.

Disclosure of information
In the case of each person who was a director at the time this report 
was approved, so far as that director is aware there is no relevant 
available information of which the Company’s auditors are unaware; 
and that director has taken all steps that the director ought to have 
taken as a director to make himself aware of any relevant audit 
information and to establish that the Company’s auditors were aware 
of that information.

Publication of accounts on the company website
Financial statements are published on the Company’s website. The 
maintenance and integrity of the website is the responsibility of the 
directors. The directors’ responsibility also extends to the financial 
statements contained therein.

Independent auditors
The auditor, Nexia Smith & Williamson Audit Limited, was appointed 
on 10 December 2019 in accordance with section 160 (2) of the 
Companies Act 2006. In accordance with S489 (4) of the Companies 
Act 2006, a resolution to re-appoint Nexia Smith & Williamson Audit 
Limited as auditor will be put to the members at the annual  
general meeting.

Signed on behalf of the board

Sarah Payne
CFO
16 March 2022

© Tern PLC: All Rights Reserved 2022  32

 
 
 
 
Chairman’s Corporate Governance Statement

Corporate Governance  
and Compliance

For the year ended 31 December 2021

As Chairman, it is my responsibility to ensure 
that good standards of corporate governance 
are embraced throughout the Company. As a 
Board, we set clear expectations concerning 
the Company’s culture, values and behaviours 
and promote good corporate governance.

The Company’s shares are traded on AIM and the Company is 
subject to the UK City Code on Takeovers and Mergers. The Board 
recognises the value and importance of high standards of corporate 
governance and applies the Corporate Governance Code 2018 (“the 
Code”) published by the Quoted Company Alliance (QCA). This 
report and the Report on Directors’ Remuneration describe how 
the Company applies certain of the provisions of good corporate 
governance. A fuller updated review describing how the Company 
applies the QCA’s ten principles of corporate governance is available 
on the Company’s website (www.ternplc.com) under Investor Zone.
The Board believes that the promotion of a corporate culture based 
on sound ethical values and behaviours is essential to creating a 
workplace environment that allows people to flourish and that this 
will contribute to enhancing shareholder value. The Company takes 
a zero-tolerance approach to bribery and corruption and has a clear 
anti-bribery policy. The Company seeks to comply with all laws, 
regulations and rules applicable to its business and to conduct that 
business in line with applicable established best practice. 

Role of the Board and how it operates
The Board has collective responsibility for setting the overall strategy 
of the Company, and for promoting the Company’s corporate values 
and culture. In discharging its role, the Board is also responsible for 
ensuring that appropriate policies, procedures and controls are in 
place to support effective risk management and performance against 
agreed strategic and financial Key Performance Indicators (KPIs).

The day-to-day management of the Board is the responsibility of 

the CEO and the executive directors. The operation of the Board is 
documented in a formal schedule of matters reserved for its approval 
which ensures appropriate oversight.
These matters include:

www.ternplc.com

 ■ Approval of the budget and any material change to it;
 ■ Oversight of the Company’s operations, including 

internal control environment; 

 ■ Changes made to the Company’s capital structure; 
 ■ Approval of financial results;
 ■ Approval of any cash injections into the network  

of companies;

 ■ Approval of regulatory news releases; and
 ■ Changes to Board structure or composition.

The Board meets at least eleven times per year, with the agendas for 
those meetings planned in advance. Standing items are included on 
each agenda, including updates from the CEO and CFO, and on the 
performance of the network of companies.
Detailed packs are prepared and circulated in advance of each 
meeting, with reports against the standing items providing updates 
on key matters for Board information and discussion, and tracking 
performance against the agreed KPIs. Board and Committee papers 
are distributed to directors in advance of the meetings, and each 
meeting is minuted by the Company Secretary. Every director is 
aware of their right to have any concerns minuted.

Composition of the Board
The Company supports the concept of effective Board leadership 
and control of the Company. The Board is responsible for approving 
Company policy and strategy. All directors have access to advice 
from the company secretary and independent professionals at the 
Company’s expense.

The Board consists of four full-time executive directors and two 

non-executive directors. The non-executive directors are independent 
of management and any business or other relationship which could 
interfere with the exercise of their independent judgement.

Ian Ritchie has been Chairman, senior independent director and a 
director of the Board for over four years. He has extensive experience 
as an independent director of listed companies and technology startup 
companies. Albert Sisto has been a director of the Board for over eight 
years and CEO for over five years. He has over 25 years of experience 
at senior executive level and with security software companies.

The Board considers that it contains a range of skills, knowledge 

and experience that are appropriate for the business. The Board 

Board Meetings 

Audit Committee 

Remuneration Committee

(out of 11) 

(out of 2) 

(out of 1) 

11 

11 

11 

11 

11 

11 

2 

21 

21 

n/a 

n/a 

2 

1

11

n/a

n/a

n/a

1

Ian Ritchie 

Albert Sisto 

Sarah Payne 

Bruce Leith 

Matthew Scherba 

Alan Howarth 

Note 1: Attendance by invitation

also believes the Board members are of sufficient ability to bring 
independent judgement on issues of strategy, performance, 
resources and standards of conduct, which are vital to the success 
of the Company. The Board believes that it operates in an open and 
constructive manner and works effectively.

Bespoke training is offered as required which covers core matters, 
such as regulatory requirements, technical training as well as personal 
skills development, to continue to develop the skill sets of the  
Board members. 

The Board members are listed on page 28.

Independence of Non-executive Directors 
The non-executive chairman and non-executive director are all 
considered by the Board to be independent of management and not 
influenced by any relationship which could interfere with the exercise 
of their independent judgement. Notwithstanding this conclusion, Ian 
Ritchie has an interest in 0.3% of the Company’s issued share capital. 
The Board is satisfied that the Chairman and the non-executive 
director devote sufficient time to the business, in accordance with the 
time commitment requirements set out in their individual letters of 
appointment, and they each maintain open communication with the 
executive directors between the formal Board meetings.

Appointment of Directors
The Board deals with all matters relating to the appointment of 
directors including determining the specification, identifying suitable 
candidates and selection of the appointee. No separate Nominations 
Committee has been formed.

The Remuneration Committee is responsible for agreeing the 

executive framework and remuneration policy.

The Articles of Association have required each director to seek re-
election after no more than three years in office. Therefore, the Board 
considers it inappropriate that non-executive directors be appointed 
for a fixed term as recommended by the Code.

Board Meetings
The Board met formally eleven times in 2021. Board meetings are 
also convened throughout the year as required and the Board met 
several times in 2021 in addition to the formal meetings to discuss 
and approve fund-raising activities for the Company and its network 
of companies.
The directors are expected to attend all Board meetings and 
Committee meetings on which they sit. The table above shows 
directors’ attendance at formal scheduled Board and Committee 
meetings during the year.

Board Evaluation
The Board carries out an evaluation of its performance as a whole 
annually, taking into account the QCA’s Guidance on Board 
Effectiveness. This process is led by the Chairman and the latest 
evaluation was carried out in August 2021. In 2021, external input was 
sought from various advisors to ensure a robust evaluation process 
which incorporated external viewpoints. As a result of this input a 
formal report is now prepared for every Board meeting summarising 
the interaction with individual shareholders during the previous 
month to ensure the Board is kept up to date on the key themes that 
are being raised and discussed.

Due to the size and nature of the company, the effectiveness of 
the individual directors is constantly evaluated and therefore it is not 
the belief of the Board that a formal process is required. Due to the 
detailed review of performance at each Board meeting, any issues 
are very quickly apparent and can be dealt with on a timely basis. As 
the company grows, the Board will periodically consider whether a 
more formal annual evaluation process is required in the future. The 
Company’s Board, individual director and Committee evaluation 
process have not changed materially over the previous years, on the 
basis that the Board as a whole consider these evaluation processes to 
be appropriate for the Company’s requirements.

Board committees
The Board has delegated specific responsibilities to the Audit and 
Remuneration Committees.  

Audit Committee
The Audit Committee was established in November 2016 and is 
chaired by Alan Howarth.

The Board endeavours to present a balanced and understandable 

assessment of the Company’s position and prospects in all reports 
as well as in the information required to be presented by statutory 
requirements. All financial information published by the Company is 
subject to the approval of the Audit Committee.

The Audit Committee is responsible for reviewing the Company’s 

internal control and risk management systems and reviewing and 
monitoring the requirement for an internal audit function and the 
effectiveness of the external audit. An internal audit function was set 
up in 2021 to undertake controls reviews in the network of companies, 
under the direction of the CFO. The CFO reports directly to the 
Committee on all findings.

The Committee is responsible for maintaining a system of internal 

control to safeguard shareholders’ investments and the Company’s 
assets and for reviewing its effectiveness. Such a system is designed 
to manage, but not eliminate the risk of failure to achieve business 

© Tern PLC: All Rights Reserved 2022  34

 
 
Chairman’s Corporate Governance Statement

“ We rely on our stakeholders for 
our success in achieving our aim 
of becoming the leading company 
specialising in IoT in the UK”

objectives. There are inherent limitations in any control system 
and accordingly even the most effective systems can provide only 
reasonable, and not absolute assurance against material misstatement 
or loss.

Activities of the Audit Committee include monitoring the integrity 
of the Company’s financial statements and other formal announcements 
relating to the Company’s financial performance and reviewing 
significant financial reporting judgements contained in them.

The Audit Committee advises the Board on the appointment, 
reappointment and removal of the external auditor, considers its 
effectiveness and approves its remuneration and terms of engagement. 
It also reviews and monitors the independence and objectivity of the 
external auditor.

There were two Audit Committee meetings in 2021. These were 

fully attended by all members.

Remuneration Committee
The Remuneration Committee was established in November 2016 
and is chaired by Alan Howarth. A detailed Remuneration Report is 
included on pages 41-42.

There was one Remuneration Committee meeting in 2021. This was 

fully attended by all members.

The Audit Committee and Remuneration Committee do not provide 

formal reports but do report to the Board on all recommendations. 
Given the size of the Company and the Board’s familiarity with the 
business of the Company, it is not considered necessary to provide 
formal reports.

External Advisors
The Board seeks advice and guidance as required throughout the 
year from its Nomad (Allenby Capital), its corporate lawyers (Reed 
Smith) and auditors (Nexia Smith & Williamson). External advice is 
also provided as required on human resources, corporate policies and 
financial PR. The Board also receives consultancy advice on any new 
company opportunities, including technical due diligence. 

Conflicts of Interest
Every director has a statutory duty under the Companies Act 2006 to 
avoid a situation in which they have a direct or indirect interest that may 
or does conflict with the interests of the Company and every director 
is required at the start of any meeting to disclose any conflicts in the 
agenda matters to be discussed. The Company’s Articles of Association 
allow for a director to vote and form part of the quorum if the conflict 
arises from a permitted cause.

Internal controls
The Board is ultimately responsible for establishing and monitoring 

www.ternplc.com

internal control systems and reviewing the effectiveness of these 
systems. The Board views the effective operation of the internal control 
environment as critical to the success of the Company.  However, it 
recognises that such systems can provide reasonable but not absolute 
assurance against material misstatement or loss. 

The CEOs meet fortnightly on a video conference with the Board and 
this provides an opportunity to discuss strategic progress but also to 
bring in external speakers, during 2021 this included a diversity and 
inclusion workshop. Regular industry relevant articles are also shared 
within this group.

The key elements of the Company’s internal control system  
are as follows:

 ■ Close management of the day-to-day activities by the 

executive directors;

 ■ An annual budgeting process which is approved by the 
Board, performance against which is reviewed at every 
Board meeting;

 ■ No single individual has the ability to authorise payments 

in excess of £2,000;

 ■ Monthly management reporting to the Board against 

agreed KPIs; and

 ■ An annual audit of the financial statements 

Share dealing, anti-bribery and whistleblowing 
The Company applies a share dealing code in conformity with the 
requirements of Rule 21 of the AIM Rules. All employees, including 
new joiners, are required to agree to comply with the code. The 
Company also has anti-bribery and whistleblowing policies, which 
are included in the Company handbook and communicated to all 
employees. The Company operates an open and inclusive culture and 
employees are encouraged to speak up if they have any concerns. 
The aim of such policies is to ensure that all directors and employees 
observe ethical behaviours and bring matters which cause them concern 
to the attention of either the executive or non-executive directors.

Our Key Stakeholders
We rely on our stakeholders for our success in achieving our aim of 
becoming the leading investment company specialising in IoT in the 
UK. Our key stakeholders are our network of companies, our people, 
our shareholders, our suppliers and the wider community within which 
we operate.

Our network of companies
Each company has a Tern nominated director who works closely 
with the companies to advise and guide with regular interactions 
throughout the month and more formally through attendance at their 
monthly board meetings.

The companies provide a report for the Board each month and the 

CEOs present at the Board meeting at least annually.

Our employees
Our people are central to the success of our business. We want to 
deliver outstanding service to our companies by ensuring our people 
are engaged and active in delivering the Company strategy. We are 
a growing company with a small number of employees, all of whom 
have regular contact with the CEO and other directors, where open 
communication and feedback is encouraged.

Our shareholders
The Company values the views of its shareholders and recognises 
their interest in the Company’s strategy and performance, Board 
membership and quality of management. It therefore encourages 
shareholders to offer their views.

We do this via a programme of events which have continued to 

be adapted to allow for the limitations placed on events by social 
distancing requirements due to the pandemic:

AGM 
The AGM provides an opportunity for shareholders, particularly 
private investors, to question the Board on issues arising in a formal 
setting and then informally immediately following the AGM. 
Directors enjoy the opportunity to engage with shareholders, answer 
their questions and meet with them informally.

The Company’s current intention is to proceed with a face-to-
face AGM. The Company will continue to monitor UK Government 
and NHS advice and members will be notified in the event that the 
Company is required to change its plans. 

The Company plans to host an online meeting after the AGM 
to present an update for the year and to provide an opportunity for 
questions to be asked by shareholders unable to attend the AGM.

Shareholder calls
A minimum of two shareholder calls per annum provide an 
opportunity for shareholders to put their questions to the Board 
and from time to time to the CEOs from our network of companies 
who are also often in attendance. These calls provide a helpful way 
of presenting an update to the shareholders on a regular basis and 
addressing their questions by taking and answering questions posed 
to the directors through this forum. The calls held during 2021 were 
hosted on a video link and this will continue to be the preferred 
format to use for future events.

Annual Report
We publish a full annual report and accounts each year where we 
articulate the strategy for the coming year and a review of the annual 
performance. The report is available in online and paper format.

Regulatory and non-regulatory news 
We issue regulatory news as required and non-regulatory news to 
communicate significant news from our network of companies and 
explain the relevance and impact of the press release.
Analyst reports are periodically prepared and issued by Progressive 
Research to provide a more indepth analysis in support of regulatory 
news updates.

Website 
The Company’s website (www.ternplc.com) maintains a 
comprehensive, up to date news flow for shareholders and other 
interested parties. A dedicated email address is provided (info@ternplc.
com) which is managed by the Company’s financial public relations 
advisors. The Company may exercise discretion as to which questions 
will receive a response and all information provided will be freely 
available in the public domain. If necessary, the enquiries will be 
brought to the Board’s attention and a summary of key themes is now 
prepared for the Board every month. There is a section dedicated to 
investors which includes financial results, analyst coverage, corporate 
governance information, information on the Board, constitutional and 
admission documents and a link to our regulatory news. 

Our suppliers
Our Company has a small number of suppliers and therefore regular 
interaction is the norm. Feedback is inherent within these interactions 
and input from specifically our nomad, brokers and PR agency have 
resulted in improved external communication and better interaction 
with our wider stakeholder groups. These parties also provide feedback 
into the annual Board Evaluation process.

Our Community
We are closely involved with each of our companies and therefore can 
influence their consideration of impact on their community. Given our 
area of expertise our companies are often involved in addressing ESG 
factors by increasing efficiencies and focusing actions on minimising 
waste. In 2022, our focus on this area will increase to ensure we are 
fulfilling our aim to have a positive impact on our environment  
and community.

Ian Ritchie 
Chairman

© Tern PLC: All Rights Reserved 2022  36

A R D

p a n y 

 is a n inte g ral p art of th e  w ay th e b u sin ess o p erates”
a n d  m a n a gin g th e p rin cip al ris ks  
“Id e ntifyin g, evalu atin g  
RIS K A N D R E W
a n d u n certainties facin g th e C o m

Business Risks

Financial risk management  
objectives and policies

The management of the business and achievement of the Company’s strategy are subject to a 
number of risks. The Board considers that the risks detailed below represent the key areas that 
could impact on achieving overall strategic objectives. The key controls over the Group’s principal 
risks and uncertainties are documented in the Company’s risk register, which includes an 
assessment of the risk, likelihood of occurrence, severity of impact and mitigating actions. 

An assessment of the strength of mitigating actions determines the 
net risk score and any further actions required. This risk register is 
reviewed regularly by the Board, with assistance from the Board 
committees. This review also assesses the effectiveness of the 
Company’s risk management and related control systems. The 
executive directors meet at least weekly to review ongoing trading 
performance for the network of companies, discuss budgets, forecasts, 
opportunities and new risks associated with ongoing trading. No 
system can fully eliminate risk and therefore, the understanding of 
operational risk is central to the management process.

Identifying, evaluating and managing the principal risks and 
uncertainties facing the Company is an integral part of the way the 
business operates. Market and economic conditions are recognised 
as one of the principal risks in the current trading environment. 
This risk is mitigated by the close monitoring of trading conditions 
and the performance of our network of companies The Company is 
affected by a number of risks and uncertainties, not all of which are 
wholly within its control as they relate to the wider macroeconomic 
and legislative environment within which the Company operates. As 
a result of the COVID-19 pandemic, the risk register was expanded 
to capture specific COVID-19 impacts and review controls which 
may be operating less effectively as a result of COVID-19 impacts. 
Also during the year an internal audit function was created to 
evaluate and assess the controls within our network of companies, 
ensuring any risks were highlighted to the Audit Committee which 
would escalate and report on the reviews to the Board.

To enable shareholders to appreciate what the business considers 

are the principal operational risks, they are briefly outlined below:

Risks include not being able to secure later rounds of funding at 

crucial development inflection points and not being able to source 
or retain appropriately skilled and experienced staff. Other risks 
arise where competing technologies enter the market, or commercial 

traction is not achieved within the forecast timeframe with 
commercial success protracted leading to severe cash flow pressure. 
Technology can be materially unproven and may ultimately fail, 
IP may be infringed, copied or stolen, may be more susceptible to 
cybercrime and other administrative taxation or compliance issues. 
These factors may lead to a reduction in value generated at the 
Company level. 

The Company does not operate in the Ukraine or Russia and is 

therefore not directly affected by the impact of the ongoing  
political conflict.

Assessment of business risk
The Board regularly reviews operating and strategic risks, with the 
assistance of its committees. The Company’s operating procedures 
include a system for reporting financial and non-financial information 
to the Board including:

 ■ reports from management with a review of the business 
at each Board meeting, focusing on any new decisions/
risks arising;

 ■ reports on the performance of the network of companies, 
this now includes a rotating monthly presentation by  
one of the network of companies’ CEOs at each  
Board meeting;

 ■ reports on selection criteria of new companies and a 
discussion around pipeline and new opportunities;

 ■ quarterly review of the risk register;
 ■ consideration of issues relating to governance and 

compliance;

 ■ reports from the sub-committees when they meet; and
 ■ consideration of reports prepared by third parties.

© Tern PLC: All Rights Reserved 2022  38

Inherent risk of building 
a network of early-stage 
companies 

Risk 
The returns and cash proceeds from the 
network of companies may be insufficient. 
The majority of the businesses are at a 
relatively early stage in their development, 
and as a result, carry inherent risks including 
technical and commercial risks. Typically, such 
companies are developing new technology or 
disrupting existing technologies in a relatively 
new sector.

Potential Impact
Risks include not being able to secure later 
rounds of funding at crucial development 
inflection points and not being able to source 
or retain appropriately skilled and experienced 
staff. Other risks arise where competing 
technologies enter the market, or commercial 
traction is not achieved within the forecast 
timeframe with commercial success protracted 
leading to severe cash flow pressure.  

Technology can be materially unproven 
and may ultimately fail, IP may be infringed, 
copied or stolen, may be more susceptible to 
cybercrime and other administrative taxation 
or compliance issues. These factors may lead 
to the Company recognising a fair value loss or 
loss on diposal.

Mitigation Strategy
The Company undergoes rigorous due 
diligence before proceeding with backing a 
new company.

The Company actively takes an influential 
role in the strategic direction of its companies 
and regularly monitors performance. A 
Company Director holds a Non-Executive 
Board position on all company boards 
The Company’s strategy has been 
formulated by the management team with 
a strong track record of generating gains 
from early-stage companies within the 
technology sector.

These mitigating factors reduce, 
although they do not eliminate, the risk of 
direct failure, particularly in the current 
pandemic-induced economic climate. A focus 
on bringing in synergistic companies and 
encouraging a strong network between them 
further mitigate the inherent risks.

Retain and attract 
successful staff 

Risk 
The Company is unable to retain key 
individuals or attract experienced, skilled and 
successful Directors.

Potential Impact
The Company depends on the experience, 
skill and judgement of the team in both 
selecting promising companies to join the 
network as well as to guide them once they 
join and the success of the Company is 
dependent on having the right individuals 
in place. 

New staff can cause disruption for the 
Company as new individuals take time to gain 
an understanding of the company’s strategy 
and requirements.

Mitigation Strategy
The Company offers balanced and 
competitive remuneration packages, overseen 
by the Remuneration Committee, designed to 
attract, motivate and retain key individuals. 
This includes the potential to receive 
performance related bonuses and share 
options.

Key individuals in the companies are 
offered a competitive remuneration package 
and either shares or share option incentives. 

Cyber security breaches

Risk 
Cyber security incidents may affect the 
operations and reputation of the Company.

Potential Impact
A significant cyber security breach could 
result in financial liabilities, reputational 
damage, business disruption or the loss of 
business critical or commercially sensitive 
information.

Mitigation Strategy
To ensure operational resilience and minimise 
the risk of occurrence of cyber security 
incidents, the Company utilises reliable 
software and hardware and operates anti-virus 
protection systems and backup procedures.

Mitigating 
Risk

Ability to maximise  
value from the network  
of companies

Risk 
The timing of disposal of a holding is 
uncertain and cash returns to the Company 
are therefore not predictable.

Potential Impact
Companies may require additional funding if 
syndication events are delayed.
The funding requirements may exceed those 
forecast in the Company cash flow.

Mitigation Strategy
The Company maintains sufficient cash 
resources to manage its ongoing operational 
and investment commitments. 

Regular operational reviews are 

undertaken by the executive team who meet 
weekly and the investment directors present a 
review of performance at each meeting. 

Financial performance of the Company is 

a standing agenda item at the Board. 

The Board meets with the CEOs from 
the network of companies every fortnight to 
discuss operational performance and other 
strategic initiatives.

Dominance of single 
company in the network  
of companies

Risk 
The network of companies is dominated by 
one or two companies.

Potential Impact
If one dominant company fails it may have a 
disproportionate impact on the Company.

Mitigation Strategy
The Company is building a network of 
companies to insulate itself against poor 
performance of any single company.

www.ternplc.com

Competition risk 

Macroeconomic issues

Business Risks

Maintain required level 
of capital to operate at 
optimum level

Risk 
The Company is unable to raise new funds due 
to a reduction in investor confidence or access 
to capital.

The timing of company realisations is 
uncertain and cash returns to the Company are 
therefore not predictable.

Potential Impact
Can result in a reduction in the ability to grow 
the network of companies or the ability to 
maintain holdings in existing companies.
May have a detrimental impact on the 
Company’s ability to fund operational costs.

Mitigation Strategy
The Company will maintain a sufficient cash 
balance to finance itself for a prudent period or 
ensure it has access to funds.

The financial performance of the Company 

is a standing agenda item at the Board 
and regular working capital reviews are 
undertaken.

Risk 
As the IoT sector becomes more mature, it 
will attract increased interest from entities 
competing with the Company.

Potential Impact
This may have a detrimental impact on the 
Company’s ability to add businesses to its 
network at an acceptable cost.

The Company may miss out on opportunities 
if it does not match prices and terms offered 
by competitors but equally it may experience 
decreased rates of return if it matches 
unfavourable terms.

Mitigation Strategy
The Company seeks to mitigate competition 
by having a diverse pipeline of opportunities 
and a proven track record of successful 
experiences with its network of companies.

The management team has a strong track 
record of providing opportunities in the USA 
for UK technology companies which should 
remain attractive to new companies.

Foreign exchange risk

ESG/Climate Change 

Risk 
The valuation of assets may be impacted by 
foreign exchange movements

Potential Impact
The value of the Company’s assets could fall.

Mitigation Strategy
The Company actively reviews the value of 
its assets and will consider action on foreign 
exchange risk where relevant, following advice 
from advisors.

The Company does not currently operate 
hedging arrangements to mitigate exposure to 
currency fluctuations but relationships are in 
place with foreign exchange service providers 
in the event the Board decides to make  
such arrangements.

Risk 
Increasing need to navigate the regulatory, 
market, technology, and reputational aspects 
associated with climate change concerns as 
well as the potential physical impacts.

Potential Impact
Transitioning to a lower-carbon economy may 
entail policy, legal, technology, and market 
changes to address mitigation and adaptation 
requirements related to climate change, which 
include changing stakeholder expectations as 
consumers and investors making decisions 
based on carbon performance and climate 
resilience. Impact on employee attraction and 
retention due to increased interest in working 
for ‘climate aware’ organisations.

Mitigation Strategy
Development of a company ESG strategy 
and working with ESG advisors to assess 
carbon footprint and target reduction as well 
as focusing on stakeholder interactions and 
ensuring the Company culture reflects all 
elements of the ESG strategy.

Risk 
This would include any further restrictions 
caused by the COVID-19 Pandemic. The 
Economic impact of COVID-19 affecting the 
performance of the Company and uncertainty 
in the Economic climate caused by  
the pandemic

Macroeconomic issues also incorporate 

the UK exit from the European Union 
and ongoing trade negotiation and related 
regulatory changes as well as the ongoing 
hostilities between Russia and Ukraine.

Potential Impact
Restrictions on movement caused by the 
pandemic can impact on the commercial 
performance of the companies. Loss of 
consumer confidence impacts on  
fundraising success.

Widespread sickness in the workforce of 

the companies may reduce the operational 
effectiveness of the business.

Detrimental impact on performance of 
companies with exposure to the European 
Union, Russia or Ukraine.

Mitigation Strategy
The Company monitors its working capital 
to ensure it has sufficient funds to maintain 
operations during any economic slow down.
The Board has taken legal advice on 
the Company’s exposure to Brexit-related 
risks and continues to monitor the impact of 
the trade discussions and the impact of the 
conflicts between Russia and Ukraine.

Reputational risk

Risk 
As a public company listed on AIM, anyone 
can acquire shares in the Company.

Potential Impact
The actions of shareholders are outside of the 
control of the Company but can impact on the 
Company by association.

Mitigation Strategy
The Board maintains regular interaction and 
communication with all its stakeholders and 
seeks to openly articulate its culture and 
strategy to shareholders at regular points 
through the year.

© Tern PLC: All Rights Reserved 2022  40

Director’s Remuneration

Director’s Remuneration

The remuneration of each director, excluding share options awards, during the year ended 31 December 2021 as detailed in the table below:

Director’s Remuneration 

For the year ended 31 December 2021

I am pleased to present our Remuneration 
Committee Report for the year ended 31 
December 2021, which summarises the work 
of the Remuneration Committee, as well as the 
remuneration policy, details of the directors’ 
remuneration packages and a summary of all 
remuneration paid to directors during the year.  

The members of the Remuneration Committee (the “Committee”) 
are Alan Howarth (Chair of the Committee) and Ian Ritchie, both of 
whom are independent non-executive directors of the Company.

The Remuneration Committee is responsible for agreeing the 
framework and remuneration policy for the executive directors. It 
sets the remuneration for the Board, agrees the terms of employment 
of all Board members, including those on cessation of employment, 
ensuring all payments are fair to both the employee and the Company; 
continues to review the appropriateness of the remuneration policies, 
with reference to the conditions across the Company and up to-date 
information on other companies, including benchmarking exercises 
carried out for AIM companies and ensures that all requirements on 
the disclosure of remuneration are fulfilled.

There was one Remuneration Committee meeting in 2021. This 

was fully attended by all members. No advice was sought by the 
Board or its Committees on any significant matters.

The activity of the Committee during the year was predominately 

focused on remuneration matters, including approving the 
remuneration increase for the executive directors and approving the 
bonus payments to the executive directors following the assessment 
of performance against agreed financial Key Performance Indicators 
(KPIs), which are designed to inspire and measure business progress. 
The Committee also approved the performance measures for the 2022 
annual bonus. The bonus amounts paid in respect of the year ended  
31 December 2021 are set out in the table on page 42.

Remuneration Policy
The policy of the Remuneration Committee is to provide executive 
remuneration packages designed to attract, motivate and retain 
directors of the calibre necessary to manage the Company and to 
reward them for enhancing shareholder value and returns. It aims 
to provide appropriate levels of remuneration to do this and have 
compensation programs that are structured at or near the midpoint  
of our peer group whilst maintaining affordability for the Company.

There are three main elements of the directors’ remuneration  
package being:

 ■ basic annual salary,
 ■ performance related bonus and
 ■ participation in the Company’s share option plan.

www.ternplc.com

Other benefits include employer contributions to pension, life 
assurance and private health insurance.

Only base salaries are pensionable. All directors’ salaries are 
reviewed annually by the Remuneration Committee. 

Executive directors’ service contracts
The executive directors are appointed under service contracts which 
are not for a fixed duration and are terminable upon six months’ notice 
by either party.

Non-executive directors
Each of the non-executive directors is appointed under a letter of 
appointment with the Company. Subject to their re¬appointment by 
shareholders, the initial term of appointment for each non-executive 
director is three years from the date of appointment and their 
appointments are terminable upon three months’ notice by either 
party. The non-executive directors’ fees are determined by the Board.

The Company Share Option Plan
The Company operates an equity settled share-based remuneration 
scheme for directors, employees and advisors. Under the director and 
employees’ scheme (issued during the year), options may be granted 
to purchase shares which must be exercised within ten years from the 
date of the grant.

The options are capable of exercise on the third anniversary of 
the grant date according to the increase in share price on the vesting 
date. If at any point prior to the third anniversary of the grant date, 
the share price increases by 100%, then 100% of the shares vests 
immediately. If there has been no increase in share price by the third 
anniversary, then 0% of the shares vest. Between these two points the 
options will vest on a straight-line basis.

No options were issued to directors during the year ended 31 

December 2021. 

Performance Related Bonus
The purpose of the bonus plan is to align the interests of selected senior 
executives of the Company with those of its shareholders. Participation 
in the Plan is at the discretion of the Board and it will enable selected 
senior executives to share in a proportion of the value realised from 
the investments made by the Company over time based on successful 
performance against KPIs set by the Board.

The annual bonus for executive directors is assessed against financial 
KPIs. Challenging targets have been set. Actual performance targets 
are not disclosed as they are considered to be commercially sensitive 
at this time.

Basic Salary 

£000 

Pension 
Contributions 
£000 

Performance 
related bonus
£000 

Other benefits 

2021 TOTAL 

2020 TOTAL

£000 

£000 

£000

EXECUTIVE DIRECTORS 

Albert Sisto 

Sarah Payne 

Bruce Leith 

Matthew Scherba 

NON-EXECUTIVE DIRECTORS 

Ian Ritchie 

Alan Howarth 

151.7 

132.0 

129.4 

129.4 

37.8 

31.5 

611.8 

15.3 

13.2 

12.9 

12.9 

- 

- 

89.9 

38.8 

38.4 

38.4 

15.7 

0.6 

12.4 

4.5 

272.5 

184.6 

193.1 

185.2 

- 

- 

- 

- 

37.8 

31.5 

54.3 

205.5 

33.2 

904.8 

Share based payment charge 

34.2 

Total remuneration 

611.8 

54.3 

205.5 

33.2 

939.0 

Note: The 2020 remuneration includes the 20% reduction in fees for six months sacrificed in the early months of the pandemic.  
This reduction was not repaid to the directors.

Director’s Share Options

The director’s outstanding share options as at 31 December 2021 are shown in the table below:

212.3

149.6

149.1

136.8

32.4

27.0

707.2

85.5

792.7

2020 

Granted 

Exercised 

Expired 

2021 

Option price 

Expiry date

EXECUTIVE DIRECTORS 

Al Sisto 

2,500,000 

Sarah Payne 

2,500,000 

Bruce Leith 

2,500,000 

Matthew Scherba 

2,500,000 

NON-EXECUTIVE DIRECTORS 

Ian Ritchie 

- 

Alan Howarth 

250,000 

- 

- 

- 

- 

- 

- 

- 

- 

- 

- 

- 

- 

-  2,500,000 

8.5p 

18 May 2027

-  2,500,000 

8.5p 

18 May 2027

-  2,500,000 

8.5p 

18 May 2027

-  2,500,000  9.15p 

1 Dec 2029

- 

- 

- 

250,000 

13p 

22 Feb 2023

Alan Howarth
Chairman of the 
Remuneration Committee

© Tern PLC: All Rights Reserved 2022  42

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Auditor’s Report

INDEPENDENT AUDITOR’S REPORT 
TO THE MEMBERS OF TERN PLC

Opinion
We have audited the financial statements of Tern Plc (the ‘company’) 
for the year ended 31 December 2021 which comprise the Income 
Statement and Statement of Comprehensive Income, the Statement of 
Financial Position, the Statement of Changes in Equity, the Statement 
of Cash Flows and the notes to the financial statements, including 
significant accounting policies.  The financial reporting framework 
that has been applied in their preparation is applicable law and 
UK-adopted international accounting standards. In our opinion, the 
financial statements:

Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities 
under those standards are further described in the Auditor’s 
responsibilities for the audit of the financial statements section 
of our report. We are independent of the company in accordance 
with the ethical requirements that are relevant to our audit of the 
financial statements in the UK, including the FRC’s Ethical Standard 
as applied to listed entities, and we have fulfilled our other ethical 
responsibilities in accordance with these requirements. We believe 
that the audit evidence we have obtained is sufficient and appropriate 
to provide a basis for our opinion. 

 ■ give a true and fair view of the state of the company’s 
affairs as at 31 December 2021 and of the company’s 
profit for the year then ended;

 ■ have been properly prepared in accordance with UK-
adopted international accounting standards; and

 ■ the financial statements have been prepared in 

accordance with the requirements of the Companies Act 
2006.

Basis for opinion
We conducted our audit in accordance with International Standards on 

Key audit matters
Key audit matters are those matters that, in our professional judgment, 
were of most significance in our audit of the financial statements of 
the current period, and include the most significant assessed risks of 
material misstatement (whether or not due to fraud) we identified, 
including those which had the greatest effect on: the overall audit 
strategy; the allocation of resources in the audit; and directing the 
efforts of the engagement team. These matters were addressed in 
the context of our audit of the financial statements as a whole, and in 
forming our opinion thereon, and we do not provide a separate opinion 
on these matters. 

KEY AUDIT MATTER

DESCRIPTION OF RISK HOW THE MATTER WAS ADDRESSED IN THE AUDIT

Our application of materiality
The materiality for the company financial statements as a whole 
was set at £1,100,000.  This has been determined with reference to 
the benchmark of the company’s net assets, which we consider to 
be one of the principal considerations for members of the company 
in assessing the company’s performance. Given the company is an 
Investment Company, as defined under IFRS 10, an earnings-based 
measure would not be appropriate. Financial Statement materiality 
represents 3.5% of the company’s net assets as presented in the 
Statement of Financial Position which aligns with the interests of 
the users of the financial statements. We also applied a specific 
materiality for all balances other than those in relation to investments 
which was set at £160,000. This is based on 10% of total expenditure 
in the year. 

Performance materiality for the company’s financial statements 

was set at £715,000, being 65% of company’s financial statement 
materiality, for purposes of assessing the risks of material 
misstatement and determining the nature, timing and extent of 
further audit procedures.  We have set it at this amount to reduce 
to an appropriately low level the probability that the aggregate 
of uncorrected and undetected misstatements exceeds financial 
statement materiality. We judged this level to be appropriate based 
on our understanding of the company and its financial statements, 
as updated by our risk assessment procedures and our expectation 
regarding current period misstatements including considering 
experience from previous audits.  The level of 65% was set due to the 
level of estimation in the investments balance.

Performance materiality, in respect of all balances other than 
those in relation to the investments balance has also been set at 65% of 
financial statement materiality, being £104,000. 

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the 
directors’ use of the going concern basis of accounting in the 
preparation of the financial statements is appropriate.  

Valuation of 
investments

Investments are the most 

For investments where there has been third party equity investments in the year, we 

significant balance on the 

compared the valuation of investments held in the balance sheet to the valuation derived 

Our evaluation of the directors’ assessment of the company’s ability to 
continue to adopt the going concern basis of accounting included:

balance sheet and the value 

from the third party fundraises into these investments.

is reliant on third party 

financial information and 

For investments listed on a recognised exchange, we compared the valuation of investments 

projections. 

held in the balance sheet to the valuation derived from the publicly available share price 

Due to the nature of the 

from the exchange as at 31 December 2021.

investments there is a lack 

For all other investments, we challenged the valuation of investments, assessing the 

of observable inputs and 

methodology used by management and corroborating key inputs/assumptions as 

therefore the key risk is 

appropriate.

considered to be the fair 

value of investments. We 

We utilised our specialist valuations team to review the validity of the methodology and 

therefore identify the 

calculations used to value the investments.  

valuation of investments held 

for trading as high risk. 

We tested the mathematical accuracy of the valuation calculations.

The company’s accounting 

policy on investments is 

shown in note 1.8 to the 

financial statements, critical 

accounting judgements and 

estimates included in note 3 

and related disclosures are 
included in note 11. 

 ■ Challenging the key assumptions used in the detailed 

budgets and forecasts prepared by management for the 
financial year to 31 December 2022 and period to 31 
March 2023; 

 ■ Assessing the mathematical accuracy of the detailed 

budgets and forecasts and agreeing to the underlying key 
assumptions; 

 ■ Comparing actual cash flow performance in 2021 to 

management’s prior year forecasts and comparing actual 
cash flow performance in 2022 so far to management’s 
2022 forecast; 

 ■ Reviewing bank statements to monitor the cash position 

of the company post year end; 

 ■ Obtaining an understanding of significant expected cash 
outflows in the forthcoming 12-month period from the 
date of signing these financial statements including any 
cash requirements the company may have to provide to 
its investee companies; and

 ■ Considering the sensitivity of the assumptions and re-

assessing headroom after sensitivity. 

any material uncertainties relating to events or conditions that, 
individually or collectively, may cast significant doubt on the 
company’s ability to continue as a going concern for a period of at 
least twelve months from when the financial statements are authorised 
for issue. 

Our responsibilities and the responsibilities of the directors  
with respect to going concern are described in the relevant sections of 
this report.

Other information
The other information comprises the information included in the 
Annual Report, other than the financial statements and our auditor’s 
report thereon. The directors are responsible for the other information 
contained within the Annual Report. Our opinion on the financial 
statements does not cover the other information and, except to the 
extent otherwise explicitly stated in our report, we do not express any 
form of assurance conclusion thereon. Our responsibility is to read 
the other information and, in doing so, consider whether the other 
information is materially inconsistent with the financial statements 
or our knowledge obtained in the course of the audit, or otherwise 
appears to be materially misstated. If we identify such material 
inconsistencies or apparent material misstatements, we are required 
to determine whether this gives rise to a material misstatement in 
the financial statements themselves. If, based on the work we have 
performed, we conclude that there is a material misstatement of this 
other information, we are required to report that fact. 

We have nothing to report in this regard. 

Opinions on other matters prescribed by the 
Companies Act 2006
In our opinion, based on the work undertaken in the course of  
the audit:

 ■ the information given in the strategic report and the 
directors’ report for the financial year for which the 
financial statements are prepared is consistent with the 
financial statements; and

 ■ the strategic report and the directors’ report have 
been prepared in accordance with applicable legal 
requirements.

Matters on which we are required to  
report by exception
In the light of the knowledge and understanding of the company 
and their environment obtained in the course of the audit, we have 
not identified material misstatements in the strategic report or the 
directors’ report.

 ■ We have nothing to report in respect of the following 
matters in relation to which the Companies Act 2006 
requires us to report to you if, in our opinion:

 ■ adequate accounting records have not been kept, or 

returns adequate for our audit have not been received 
from branches not visited by us; or

 ■ the financial statements are not in agreement with the 

accounting records and returns; or

 ■ certain disclosures of directors’ remuneration specified 

by law are not made; or

 ■ we have not received all the information and explanations 

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  44

Based on the work we have performed, we have not identified 

we require for our audit.

 
Auditor’s Report

Responsibilities of directors
As explained more fully in the directors’ responsibilities statement 
set out on page 31, the directors are responsible for the preparation of 
the financial statements and for being satisfied that they give a true 
and fair view, and for such internal control as the directors determine 
is necessary to enable the preparation of financial statements that are 
free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible 

for assessing the company’s ability to continue as a going concern, 
disclosing, as applicable, matters related to going concern and using 
the going concern basis of accounting unless the directors either 
intend to liquidate the company or to cease operations, or have no 
realistic alternative but to do so. 

Auditor’s responsibilities for the audit of the 
financial statements
Our objectives are to obtain reasonable assurance about whether the 
financial statements as a whole are free from material misstatement, 
whether due to fraud or error, and to issue an auditor’s report 
that includes our opinion.  Reasonable assurance is a high level 
of assurance, but is not a guarantee that an audit conducted 
in accordance with ISAs (UK) will always detect a material 
misstatement when it exists.  Misstatements can arise from fraud or 
error and are considered material if, individually or in the aggregate, 
they could reasonably be expected to influence the economic 
decisions of users taken on the basis of these financial statements. 
The extent to which our procedures are capable of detecting 
irregularities, including fraud, is detailed below.  Irregularities, 
including fraud, are instances of non-compliance with laws and 
regulations.  We design procedures in line with our responsibilities, 
outlined above, to detect material misstatements in respect of 
irregularities, including fraud.  

We obtained an understanding of the legal and regulatory 
framework applicable to the company as well as the laws and 
regulations applicable, and considered these throughout our testing. 
We obtained an understanding of the entity’s policies and procedures 
by discussions with management. We also drew on our existing 
understanding of the company’s industry and regulation. 

We understand the company complies with requirements of these 
frameworks through:  

 ■ The Directors updating operating procedures, 

manuals and internal controls as legal and regulatory 
requirements change. 

 ■ The Directors’ close involvement in the day-to-day 

running of the business, meaning that any litigation or 
claims would come to their attention directly.

In the context of the audit, we considered those laws and 
regulations: which determine the form and content of the financial 
statements; which are central to the company’s ability to conduct 
business; and where failure to comply could result in material 
penalties. We have identified the following laws and regulations as 
being of significance in the context of the company: 

 ■ The Companies Act 2006 and IFRS in respect of the 

preparation and presentation of the financial statements; 
and 

 ■ AIM regulations and Market Abuse Regulations 

We performed the following specific procedures to gain evidence 
about compliance with the significant laws and regulations above; 

 ■ We have reviewed a sample of legal and  

professional invoices 

 ■ Made enquiries with management as to any legal or 

regulatory issues during the year 

 ■ We have reviewed Board minutes for evidence of  

non compliance 

 ■ We have confirmed with management there has been no 

correspondence with the FRC during the year 

 ■ We have obtained representation from management that 
they have disclosed to us all known instances of non-
compliance or suspected non-compliance with laws  
and regulations 

The senior statutory auditor led a discussion with senior members 

of the engagement team regarding the susceptibility of the entity’s 
financial statements to material misstatement, including how fraud 
might occur. The key areas identified as part of the discussion were 
with regard to the manipulation of the financial statements through 
manual journals and inflation of investment values. This was 
communicated to the other members of the engagement team who 
were not present at the discussion. 

The procedures carried out to gain evidence in the above  
areas included; 

 ■ Testing of the investments balance as described in the key 

audit matters section above; and 

 ■ Testing of manual journal entries, selected based on 

specific risk assessments applied based on the company’s 
processes and controls surrounding manual journals. 

The senior statutory auditor was satisfied that the engagement 
team collectively had the appropriate competence and capabilities 
to identify or recognise irregularities. In particular, both the senior 
statutory auditor and the audit manager have a number of years’ 
experience in dealing with companies subject to AIM Regulation.
A further description of our responsibilities is available on the 

FRC’s website at: www.frc.org.uk/auditorsresponsibilities.  This 
description forms part of our auditor’s report.

Use of our report 
This report is made solely to the company’s members, as a body, in 
accordance with Chapter 3 of Part 16 of the Companies Act 2006.  
Our audit work has been undertaken so that we might state to the 
company’s members those matters we are required to state to them 
in an auditor’s report and for no other purpose.  To the fullest extent 
permitted by law, we do not accept or assume responsibility to anyone 
other than the company and the company’s members as a body, for our 
audit work, for this report, or for the opinions we have formed.

Sancho Simmonds
Senior Statutory Auditor, for and on behalf of   
Nexia Smith & Williamson 
Statutory Auditor 
Chartered Accountants 
25 Moorgate,  
London EC2R 6AY 
16 March 2022

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  46

Financials 2021

Income Statement and Statement of 
Comprehensive Income

For the year ended 31 December 2021

Fee income  

Notes 

2021 
£ 

2020 
£

63,783 

151,159

Movement in fair value of investments 

11 

6,240,095 

1,992,891

Loss on disposal 

Total investment income  

Administration costs  

Other expenses 

Operating profit 

Finance income 

Profit before tax 

Tax 

(199,115) 

–

6,104,763 

2,144,050

(1,635,058) 

(1,341,802)

(75,372) 

(206,845)

4,394,333 

183,988 

4,578,321 

– 

595,403

208,488

803,891

–

6 

7 

8 

9 

Profit and total comprehensive income for the period 

4,578,321 

803,891

Since there is no other comprehensive income, the profit for the year is the same as the total comprehensive income for the year.

EARNINGS PER SHARE

Basic earnings per share 

Diluted earnings per share 

10 

10 

1.35 pence 

0.30 pence

1.33 pence 

0.30 pence

Financials 2021

www.ternplc.co.uk

© Tern PLC: All Rights Reserved 2022  48

The accompanying accounting policies and notes are an integral part of these financial statements.

 
 
 
 
 
 
 
  
  
Statement of Financial Position
As at 31 December 2021

Statement of Changes in Equity
For the year ended 31 December 2021

Notes 

2021 
£ 

2020 
£

Share capital  Share premium 
£ 

£ 

Retained earnings 
£ 

Total equity 
£

Financials 2021

Balance at 31 December 2019 

1,355,571 

22,578,619 

(5,021,113) 

18,913,077

Total comprehensive income 

– 

– 

803,891 

803,891

TRANSACTIONS WITH OWNERS 

Issue of share capital 

12,064 

4,488,336 

Share issue costs 

Share based payment charge 

– 

– 

(326,166) 

– 

– 

4,500,400

(326,166)

– 

109,455 

109,455

Balance at 31 December 2020 

1,367,635 

26,740,789 

(4,107,767) 

24,000,657

Total comprehensive income 

– 

– 

4,578,321 

4,578,321

TRANSACTIONS WITH OWNERS 

Issue of share capital 

4,335 

4,031,665 

Share issue costs 

Share based payment charge 

– 

– 

(225,885) 

– 

– 

4,036,000

(225,885)

– 

27,456 

27,456

Balance at 31 December 2021 

1,371,970 

30,546,569 

498,010 

32,416,549

ASSETS
NON-CURRENT ASSETS

Investments 

CURRENT ASSETS 

Trade and other receivables 

Cash and cash equivalents 

TOTAL ASSETS 

EQUITY AND LIABILITIES 

Share capital 

Share premium 

Retained earnings 

CURRENT LIABILITIES 

Trade and other payables 

TOTAL CURRENT LIABILITIES 

TOTAL LIABILITIES 

11 

12 

13 

14 

14 

15 

16 

30,612,047 

30,612,047 

21,904,791

21,904,791

189,354 

1,957,203 

2,146,557    

261,301

2,130,166

2,391,467

32,758,604 

24,296,258

1,371,970 

1,367,635

30,546,569 

26,740,789

498,010 

(4,107,767)

32,416,549 

24,000,657

342,055 

342,055 

342,055 

295,601

295,601

295,601

TOTAL EQUITY AND LIABILITIES 

32,758,604 

24,296,258

The financial statements were approved 
and authorised for issue by the Board 
of Directors on 16 March 2022 and were 
signed on its behalf by:

Sarah Payne
Director

Company number 05131386

The accompanying accounting policies and notes are an integral part of these financial statements.

The accompanying accounting policies and notes are an integral part of these financial statements.

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  50

 
 
 
  
 
  
  
 
  
  
  
  
  
 
  
  
  
  
 
  
  
  
 
 
 
  
  
 
 
  
  
 
Statement of Cash Flows

For the year ended 31 December 2021

Notes 

2021 
£ 

2020 
£

OPERATING ACTIVITIES 

Net cash used in operations 

20 

Purchase of investments 

Cash received from sale of investments 

Interest received 

(1,535,722) 

(2,504,185) 

– 

56,829 

(1,189,481)

(1,957,248)

93,421

1,275

Net cash used in operating activities 

(3,983,078) 

(3,052,033)

FINANCING ACTIVITIES 

Proceeds on issues of shares 

Share issue expenses 

Proceeds from exercise of options 

Net cash from financing activities 

(Decrease)/increase in cash and cash equivalents 

Cash and cash equivalents at beginning of year 

Cash and cash equivalents at end of year 

4,000,000 

(225,885) 

36,000 

3,810,115 

(172,963) 

2,130,166 

1,957,203 

4,500,400

(326,166)

–

4,174,234

1,122,201

1,007,965

2,130,166

The accompanying accounting policies and notes are an integral part of these financial statements.

www.ternplc.com

Financials 2021

Notes to the Financial Statements

For the year ended 31 December 2021

1. ACCOUNTING POLICIES
The principal accounting policies adopted in the preparation of these 
financial statements are set out below. 

1.1 GENERAL INFORMATION
Tern plc is an investing company specialising in private software 
companies, predominantly in the Internet of Things.

The Company is a public limited company, incorporated in England 
and Wales, with its shares traded on AIM, a market of that name 
operated by the London Stock Exchange.

The address of Tern’s registered office is 27/28 Eastcastle Street, 
London W1W 8DH. Items included in the financial statements of the 
Company are measured in Pound Sterling, rounded to the nearest 
pound which is the Company’s presentational and functional currency.

1.2 BASIS OF PREPARATION
The financial statements of the Company have been prepared in 
accordance with UK-adopted international accounting standards. 
The financial statements have been prepared on the basis of the 
recognition and measurement principles of the IFRS that were 
applicable at 31 December 2021.

The preparation of financial statements in conformity with generally 
accepted accounting principles requires the use of estimates and 
assumptions that affect the reported amounts of assets and liabilities 
at the date of the financial statements and the reported amounts of 
revenues and expenses during the reporting period. Although these 
estimates are based on management’s best knowledge of the amount, 
event or actions, actual results may ultimately differ from  
those estimates.

The financial statements have been prepared on the historical cost 
basis except for investments and certain financial instruments 
which are measured at fair value at the end of each reporting period. 
Historical cost is generally based on the fair value of the consideration 
given in exchange for the assets. The principal accounting policies 
set out below have been consistently applied to all periods presented, 
except where stated.

In accordance with IFRS 10, para 4 the directors consider the 
Company to be an investment company and have taken the exemption 
not to present consolidated financial statements or apply IFRS3 when 
it obtains control of another entity as it is an investing company 
that measures all of its investments at fair value through the income 
statement in accordance with IFRS 9.

1.3 GOING CONCERN
The financial statements have been prepared on the going  
concern basis.

The directors have a reasonable expectation that the Company has 
adequate resources to continue operating for the foreseeable future. 
For this reason, they continue to adopt the going concern basis in 

preparing the Company’s financial statements. This has been assessed 
using detailed cash flow analysis so that the Board can conclude that 
the Company has sufficient working capital resources to continue 
for at least 12 months from the approval of the financial statements 
without any additional financing requirement. A review of a variety  
of macro-economic factors including COVID-19 have been 
considered as part of this assessment. In the event that opportunities 
are presented such that additional funding was required, management 
are confident that they would be able to obtain additional funds 
from various sources. For example, the Company can exit part of its 
investment in its held level one investments with the risk that such 
transactions are determined by an inherent and undetermined  
market risk. 

1.4 STATEMENT OF COMPLIANCE
International Financial Reporting Standards (“Standards”) in 
issue but not yet effective

The Company has not applied the following new and revised IFRSs 
that have been issued but are not yet effective and are expected to 
relate to the Company:

 ■ IAS 1 Presentation of Financial Statements: amendments 
regarding the disclosure of accounting policies (issued in 
February 2021 and effective for annual periods beginning 
on or after 1 January 2023).

 ■ IAS 8 Accounting Policies, Changes in Accounting 
Estimates and Errors: amendments regarding the 
definition of accounting estimates (issued in February 
2021 and effective for annual periods beginning on or 
after 1 January 2023).

1.5 ADOPTION OF NEW AND REVISED STANDARDS
There are no new standards adopted by the Company in the 
financial year.

1.6 FEE INCOME
Under IFRS 15, fee income is recognised at an amount that reflects 
the consideration to which the Company is expected to be entitled 
in exchange for transferring services to an investee company or 
recharging legal advice to an investee company. For each contract 
with an investee company there is only one performance obligation 
in the contract and the transaction price is readily identifiable. Fee 
income is recognised as each performance obligation is satisfied in a 
manner that depicts the transfer to the investee company of the goods 
or services promised.

There is no variable consideration within the transaction price.

Fee income from a contract to provide services is recognised over 
time as the services are rendered based on either a fixed price or an  
hourly rate.

© Tern PLC: All Rights Reserved 2022  52

 
 
 
  
  
 
  
 
  
  
  
  
 
  
  
 
  
  
  
  
 
Notes to the Financial Statements
For the year ended 31 December 2021

1. ACCOUNTING POLICIES (continued)

1.7 TAXATION
The tax expense represents the sum of the tax currently payable and 
any deferred tax. The charge for current tax is based on the results 
for the period as adjusted for items which are non-assessable or 
disallowed. It is calculated using rates that have been enacted or 
substantively enacted by the statement of financial position date.
Deferred tax assets and liabilities are recognised where the carrying 
amount of an asset or liability in the statement of financial position 
differs to its tax base, except for differences arising on:

1.11 CASH AND CASH EQUIVALENTS
Cash and cash equivalents are carried in the statement of financial 
position. Cash and cash equivalents comprise cash in hand, deposits 
held at call with banks and other short term highly liquid investments 
with original maturities of three months or less.

1.12 TRADE PAYABLES
Trade payables are financial liabilities measured at amortised cost in 
accordance with IFRS 9.

1.13 EQUITY INSTRUMENTS
Equity instruments are recorded at the proceeds received net of direct 
issue costs.

1.14 SHARE BASED PAYMENTS
All share based payments are accounted for in accordance with IFRS 
2 – “Share based payments”. The Company issues equity-settled share 
based payments in the form of share options to certain directors, 
employees and advisors. Equity settled share based payments are 
measured at fair value at the date of grant. The fair value determined 
at the grant date of equity-settled share based payments is expensed 
on a straight line basis over the vesting period, with a corresponding 
adjustment to retained earnings, based on the Company’s estimate of 
shares that will eventually vest.

Fair value is estimated using the Black-Scholes model as relevant 
for the terms and conditions of the options. The expected life used 
in the model has been adjusted, on the basis of management’s best 
estimate for the effects of non-transferability, exercise restrictions and 
behavioral considerations. At each statement of financial position date, 
the Company revises its estimate of the number of equity instruments 
expected to vest as a result of the effect of non-market based vesting 
conditions. The impact of the revision of the original estimates, if any, 
is recognised in profit or loss such that the cumulative expense reflects 
the revised estimate, with a corresponding adjustment to  
retained earnings.

 ■ the initial recognition of an asset or liability which is not 
a business combination and at the time of the transaction 
affects neither accounting or taxable profit; and

 ■ investments in subsidiaries and jointly controlled entities 
where the Company is able to control the timing of the 
reversal of the difference and it is probable that the 
difference will not reverse in the foreseeable future.

Recognition of deferred tax assets is restricted to those instances 
where it is probable that the taxable profit will be available against 
which the differences can be utilised.

The amount of the asset or liability is determined using tax rates that 
have been enacted or substantially enacted by the reporting date and 
are expected to apply when the deferred tax liabilities/(assets) are 
settled/(recovered). Deferred tax balances are not discounted.

1.8 INVESTMENTS
The investment consists of equity investments and convertible loan 
notes issued to an investee company. The convertible loan notes are 
financial assets with multiple embedded derivatives which can include 
a warrant instrument. These financial assets are measured in their 
entirety at FVTPL.

In accordance with IFRS 10, paragraph 4B, investments are 
recognised at FVTPL in line with guidance set out in IFRS 9. Changes 
in foreign exchange rates impact investments valued in a foreign 
currency.

1.9 IMPAIRMENT OF FINANCIAL ASSETS
Assets carried at fair value through profit or loss (FVTPL)
Under IFRS 9 no impairment testing is required for equity 
investments which are measured at fair value through profit or loss 
(“FVTPL”).

1.10 TRADE RECEIVABLES
Trade receivables are classified as a financial asset and are valued at 
amortised cost in accordance with IFRS 9. A provision for impairment 
of trade receivables is established when there is objective evidence 
that the Company will not be able to collect all amounts due according 
to the original terms of receivables. The amount of the provision 
is calculated as the change in lifetime expected credit losses and 
recognised in the income statement, in accordance with IFRS 9.

CREDIT RISK
The Company’s primary credit risk arises from loans made to its 
investee companies and trade receivables. Financial instruments 
that potentially subject the Company to concentrations of credit risk 
consist primarily of accounts receivable and derivative instruments. 
These instruments contain a risk of counterparties failing to discharge 
their obligations. The Company monitors credit risk and manages 
credit risk exposure by type of financial instrument by assessing the 
creditworthiness of counterparties. The Company does not anticipate 
non-performance by counterparties; however it generally requires 
security over the companies’ assets to support financial instruments 
with credit risk.

The Company derives its fee income from a small number of 
investments. Fee income to these investee companies is not expected 
to fluctuate significantly and is not significant in value.

The credit risk on loans is low as the expectation is to convert 
loan balances on realisation of the assets. The credit risk on trade 
receivables is low due to the generally low balance held.

The maximum credit exposure is equal to the carrying values of cash 
at bank, accounts receivables and investments.

2.2 CAPITAL RISK MANAGEMENT
The Company’s objectives when managing capital are to safeguard 
the Company’s ability to continue as a going concern in order to 
provide returns for shareholders, benefits for other stakeholders and to 
maintain an optimal capital structure to reduce the cost of capital.

The Company monitors capital on the basis of the carrying amount 
of equity plus debt as presented on the face of the statement 
of financial position. In order to maintain or adjust the capital 
structure, the Company may adjust the amount of dividends paid to 
shareholders, return capital to shareholders, issue new shares or sell 
assets to reduce debt.

2.3 FAIR VALUE ESTIMATION
Refer to note 17 for the fair value estimation accounting policy.

2. FINANCIAL RISK MANAGEMENT
The Company uses a limited number of financial instruments; 
comprising cash, convertible loans and various items such as trade 
receivables and payables, which arise directly from operations.  
The Company does not trade in financial instruments.

2.1 FINANCIAL RISK FACTORS
The Company’s financial instruments comprise its investment 
portfolio, loans to investee companies, cash balances, debtors and 
creditors that arise directly from its operations. The Company is 
exposed to market risk through the use of financial instruments and 
specifically to liquidity risk, market price risk and credit risk, which 
result from the Company’s operating activities.

The Board’s policy for managing these risks is summarised below. 

LIQUIDITY RISK
The Company makes investments in predominantely private 
companies for the medium term which are therefore not immediately 
liquid. The Company manages this risk by holding cash to support 
its investments and for working capital. The Company ensures it has 
sufficient cash through a combination of means including proceeds 
from asset sales, equity raises and, in the past, the use of convertible 
loan notes. The financial performance and position of the investee 
companies are regularly monitored to assess when further investment 
may be required, this includes a review of cash flow forecasts. 
The Company has a quoted investment which may be sold to meet the 
Company’s funding requirements. 

The Company’s income and operating cash flows are substantially 
independent of changes in market interest rates.

MARKET PRICE RISK
As the Company owns quoted investments, it will be exposed  
to market price risk as shown by movements in the value of its equity 
investments. Any such risk will be regularly monitored by  
the directors.

The unquoted investments currently held are not liquid.

FOREIGN EXCHANGE RISK
The Company generally conducts its business within the UK, however 
some of its investments are valued based on a foreign currency 
valuation. Device Authority, the most significant investment, is based 
on a US dollar valuation and Wyld Networks is based on a SEK 
valuation and therefore their value can change dependent on currency 
exchange movement. To the extent that exchange rate fluctuations 
impact the value of the Company’s investments in its foreign 
operations, they are not hedged.

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  54

Notes to the Financial Statements
For the year ended 31 December 2021

3. CRITICAL ACCOUNTING 
ESTIMATES AND JUDGEMENTS
Estimates and judgements are continually evaluated and are based 
on historical experience and other factors, including expectations 
of future events that are believed to be reasonable under the 
circumstances.

JUDGEMENTS
Investments held at FVTPL
The critical judgement is the assessment that investments should be 
consolidated. This assessment was reached following a review of all 
the key conditions for an investment entity, as set out in IFRS 10 and 
the Company was judged to have met those key conditions as follows:

The Company makes estimates and assumptions concerning the 
future. The resulting accounting estimates will, by definition, rarely 
equal the related actual results. The key sources of estimation 
uncertainty that have a significant risk of causing a material 
adjustment to the carrying amounts of assets and liabilities within the 
next financial year are outlined below.

ESTIMATES
Fair value of financial instruments
As set out in note 11, the Company holds unquoted investments 
of £21.9m that have been designated as held for trading on initial 
recognition. Where practicable the Company determines the fair 
value of these financial instruments that are not quoted (Level 3) 
using the most recent bid price at which a transaction has been 
carried out. These techniques are significantly affected by certain 
key assumptions, such as market liquidity. Given the nature of the 
investments being early-stage business, other valuation methods such 
as discounted cash flow analysis to assess estimates of future cash 
flows and derive fair value estimates cannot always be substantiated 
by comparison with independent markets and, in many cases, may not 
be capable of being realised immediately.

The Company holds financial assets that have been held at FVTPL. 
The value of the convertible loan notes has been estimated by 
assessing the probability of each possible redemption or conversion 
scenario and accounting for this within the overall fair  
value assessment.

 ■ The Company obtains funds from one or more investors for 
the purpose of providing those investor(s) with investment 
management services;

 ■ The Company commits to its investors that its business 
purpose is to invest funds solely for returns from capital 
appreciation, investment income, or both; and

 ■ The Company measures and evaluates the performance of 
substantially all of its investments on a fair value basis.
 ■ In coming to this conclusion, the Company also judged that 
its investment-related activities do not represent a separate 
substantial business activity or a separate substantial source 
of income to the investment entity.

4. SEGMENTAL REPORTING
The accounting policy for identifying segments is based on internal 
management reporting information that is regularly reviewed by the 
chief operating decision maker, which is identified as the Board of 
Directors.

In identifying its operating segments, management generally follows 
the Company’s service lines which represent the main products 
and services provided by the Company. The directors believe that 
the Company’s continuing investment operations comprise one 
segment and therefore the figures presented on the face of the income 
statement and statement of financial position represent the segmental 
information.

5. STAFF COSTS
Staff costs for the Company during the year, including directors 

Wages and salaries 

Consultancy fees 

Social security costs 

Pension costs 

Share based payment charge 

Total staff costs 

The average number of people (including non-executive directors)  
employed by the Company during the year was:

Directors  

Employees 

Total 

2021 

£ 

2020

£

909,060 

690,771

– 

85,083 

59,709 

17,500

66,911

56,216

27,456 

109,455

1,081,308 

940,853

2021 

No 

6 

1 

7 

2020

No

6

1

7

DIRECTORS’ REMUNERATION 
Other than directors the Company had one employee as at 31 December 2021. Total remuneration paid to directors during the year was as follows:

DIRECTORS’ REMUNERATION 

– Salaries and benefits 

– Consultancy fees 

– Social security costs 

– Pension costs 

– Share based payment charge 

Total directors’ remuneration 

2021 

£ 

2020

£

850,455 

638,353

– 

78,770 

54,309 

17,500

61,387

51,475

34,187 

85,468

1,017,721 

854,183

Total remuneration of the highest paid director was  

272,541 

212,301

A summary of remuneration paid to each director, including pension payments, is included in the Report on Directors’ Remuneration 
(page 41-42).

Key management personnel is deemed to consist solely of the statutory directors.

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  56

 
  
 
 
 
  
 
 
 
  
 
Notes to the Financial Statements
For the year ended 31 December 2021

6. OTHER EXPENSES

9. TAXATION

Share based payment (options) 

One-off legal and professional costs 

Recharged professional fees 

Charitable donations 

7. OPERATING PROFIT

2021 

£ 

27,456 

31,916 

6,000 

10,000 

75,372 

2021 

£ 

2020

£

109,455

1,613

85,777

10,000

206,845

2020

£

PROFIT FROM OPERATIONS HAS BEEN ARRIVED AT AFTER CHARGING   

Remuneration of directors 

1,017,721 

854,183

FEES PAYABLE TO THE COMPANY’S AUDITOR FOR SERVICES PROVIDED TO THE COMPANY  

– Audit services 

– Tax compliance services 

– Advisory services 

– Audit related services 

8. FINANCE INCOME

Bank interest 

Interest income on loan notes 

Interest accrued on convertible loan notes 

35,000 

4,675 

1,025 

3,000 

2021 

£ 

– 

21,897 

162,091 

183,988 

33,250

4,450

1,662

3,000

2020

£

1,275

–

207,213

208,488

Profit before tax 

Tax at domestic income tax rate 

Expenses not deductible for tax purposes 

Income not taxable 

Unutilised tax losses 

Tax  

2021 
£ 

4,578,321 

869,881 

6,026 

(1,185,618) 

309,711 

– 

2020
£

803,891

152,739

21,139

(380,639)

206,761

–

The Company has unutilised losses of approximately £9.4m (2020: £7.7m) resulting in a deferred tax asset not recognised of approximately £1.7m 
(2020: £1.4m). The losses do not have an expiry date. The Company has not recognised a deferred tax asset in respect of these losses as there is 
insufficient evidence of future taxable profits. The Company has not recognised a deferred tax liability in respect of fair value gains on investments 
as most asset sales are expected to be exempt from taxation due to the substantial shareholding exemption (SSE).

10. EARNINGS PER SHARE

Profit for the purposes of basic and fully diluted profit per share 

4,578,321 

2021 
£ 

2020 
£

803,891

2021 
Number 

2020 
Number

WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES 

For calculation of basic earnings per share 

339,559,205 

290,768,708

For calculation of fully diluted earnings per share 

342,975,205 

290,768,708

EARNINGS PER SHARE: 

Basic earnings per share 

Diluted earnings per share 

2021 

2020

1.35 pence 

1.33 pence 

0.30 pence

0.30 pence

In 2020 the fully diluted earnings per share is the same as the basic earnings per share as the share options were underwater which would have an 
anti-dultive effect on earnings per share. 

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  58

 
 
  
 
 
 
 
 
 
  
 
 
 
 
  
 
  
 
  
  
 
Notes to the Financial Statements
For the year ended 31 December 2021

11. NON CURRENT ASSETS

INVESTMENTS 

Fair value of investments brought forward 

Interest accrued on convertible loan note 

Additions 

Disposals 

Fair value of investments carried forward 

Fair value adjustment to investments 

Fair value of investments carried forward 

Wyld Networks AB 

Device Authority Limited  

InVMA Limited (Konektio) 

FVRVS Limited (FundamentalVR) 

Talking Medicines Limited 

Push Technology Limited 

12. TRADE AND OTHER RECEIVABLES

2020 
£

17,882,660

Trade receivables 

Prepayments 

Interest receivable on convertible loan note 

Other receivables 

Total 

2021 
£ 

21,904,791 

162,091 

2,504,185 

(199,115) 

24,371,952 

6,240,095 

30,612,047 

171,473

1,957,248

(99,481)

19,911,900

1,992,891

21,904,791

2021 

£ 

102,959 

63,850 

808 

21,737 

189,354 

2020

£

166,564

36,753

35,740

22,244

261,301

The directors consider that the carrying amount of trade and other receivables approximates to its fair value.  
There is no provision for bad debt. The other classes within trade and other receivables do not contain impaired assets.
The maximum exposure to credit risk at the reporting date is the fair value of the trade receivables which all relate to receivables  
from our investments.

13. CASH AND CASH EQUIVALENTS

Cash at bank 

2021 
£ 

2020
£

1,957,203 

2,130,166

The directors consider that the carrying amount of cash at bank is a reasonable approximation to its fair value.

Cost  

Valuation 

Equity ownership 

£000 

1,788 

8,565 

1,525 

2,928 

860 

120 

15,786 

£000 

8,746 

14,686 

2,189 

3,576 

1,392 

23 

30,612 

%

58.7

53.8

36.8

26.9

23.4

<1

The convertible loan facility issued to FVRVS is a financial asset with multiple derivatives and the entire contract has been designated at FVTPL, 
with any movement in fair value taken to profit or loss for the year. In 2021 the value of the convertible loan outstanding was £530,000 (2020: nil)

The convertible loan facilities issued to Device Authority, InVMA and Wyld Networks were converted into equity during the year with any 
movements in fair value taken to profit or loss for the year.

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  60

 
 
 
 
 
 
 
 
Notes to the Financial Statements
For the year ended 31 December 2021

14. ISSUED SHARE CAPITAL

ISSUED AND FULLY PAID

AT 31 DECEMBER 2020 

Ordinary shares of £0.0002 

Deferred shares of £29.999 

Deferred shares of £0.00099 

Number of shares  
no. 

Nominal value  
£ 

Share premium 
£

15. RESERVES
Details of the movements in reserves are set out in the Statement of 
Changes in Equity. A description of each reserve is set out below.

Share capital
The amount subscribed for shares at nominal value. 

330,338,101 

42,247 

34,545,072 

66,067 

1,267,368 

34,200 

364,925,420 

1,367,635 

26,740,789

16. TRADE AND OTHER PAYABLES

Ordinary shares issued for cash 

21,676,600 

Share issue expenses 

– 

4,335 

– 

4,031,665

(225,885)

Trade payables 

386,602,020 

1,371,970 

30,546,569

Accruals and deferred income 

Other taxes and social security 

Total 

The directors consider that the carrying amount of trade payables approximates to its fair value.

AT 31 DECEMBER 2021 

Ordinary shares of £0.0002 

Deferred shares of £29.999 

Deferred shares of £0.00099 

352,014,701 

42,247 

34,545,072 

386,602,020 

70,402 

1,267,368 

34,200 

1,371,970 

30,546,569

Ordinary Shares
The shares have attached to them full voting, dividend and capital distribution (including on winding up) rights. They do not confer any rights  
of redemption.

Deferred shares of £29.999
The shares have no voting or dividend rights. There are no capital distribution (including on winding up) rights, other than to receive the nominal 
amount paid on the shares, after the ordinary shareholders have received the sum of £100 per share.

Deferred shares of £0.00099
The shares have no voting or dividend rights. There are no capital distribution (including on winding up) rights, other than to receive the nominal 
amount paid on the shares. The Company has the right to purchase all the shares for £1.

On 13 July 2021, 21,276,600 ordinary shares were issued at 18.8p per share for cash as the result of a private placing raising £4,000,000 before 
expenses. On 21 December 2021, 400,000 ordinary shares of 0.02p were issued to a former director of the Company on exercise of options at  
9p per share.

Share premium
This represents the excess of the amount subscribed for share capital 
over the nominal value of the respective shares net of share issue 
expenses.

Retained earnings
Cumulative profit of the Company.

2021 
£ 

75,232 

217,361 

49,462 

342,055 

2020 
£

104,066

138,726

52,809

295,601

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  62

 
 
 
 
  
  
 
 
 
 
  
  
  
  
 
 
 
 
 
Notes to the Financial Statements
For the year ended 31 December 2021

17. FAIR VALUE MEASUREMENT 

FINANCIAL ASSETS
The Company classifies its financial instruments in the following 
categories: at fair value through profit or loss or amortised cost. 
The classification depends on the purpose for which the financial 
instrument was acquired. Management determines the classification 
of its financial instruments at initial recognition and re-evaluates this 
designation at each financial period end.

When financial assets are recognised initially, they are measured 
at fair value, being the transaction price plus directly attributable 
transaction costs.

FAIR VALUE THROUGH PROFIT OR LOSS (FVTPL) 

Investments
All investments are determined upon initial recognition as held at fair 
value through profit or loss. Investment transactions are accounted for 
on a trade date basis. Asset sales are recognised at the trade date of the 
disposal. The fair value of the financial instruments in the statement of 
financial position is based on the last transaction price at the statement 
of financial position date, with no deduction for any estimated future 
selling cost. Unquoted investments are valued by the directors using 
primary valuation techniques such as recent transactions and last 
price. Changes in the fair value of investments held at fair value 
through profit or loss and gains and losses on disposal are recognised 
in the statement of comprehensive income as “movement in fair value 
of investments”. Investments are measured at fair value in accordance 
with IFRS 9. Details of the valuation technique for each individual 
investment is set out in the Financial Review on page 25-26.

The Company determines the fair value of its investments based 
on the following hierarchy:

LEVEL 1 – Where financial instruments are traded in active 
financial markets, fair value is determined by reference to the 
appropriate quoted market price at the reporting date. Active 
markets are those in which transactions occur in significant 
frequency and volume to provide pricing information on an on-
going basis.

LEVEL 2 – If there is no active market, fair value is established 
using valuation techniques, including discounted cash flow 
models. The inputs to these models are taken from observable 
market data including recent arm’s length market transactions 
and comparisons to the current fair value of similar instruments; 
but where this is not feasible, inputs such as liquidity risk, credit 
risk and volatility are used.

LEVEL 3 – Valuations in this level are those with inputs that are 
not based on observable market data.

The following table shows the levels within the hierarchy of 
investments measured at fair value on a recurring basis at 31 
December 2021 and 31 December 2020:

For Level 3 investments, the fair value assessment was made 
by the directors using the price of the shares in the most recent 
fundraise, where this was available, as well as an assessment of 
market valuations placed on comparable businesses, a review of the 
underlying asset values and a review of the sales pipeline and forecast 
to support any valuation applied. 

Convertible loans provided to investment companies are evaluated 
with reference to IFRS 9. The financial asset will be measured and 
accounted for at FVTPL. Assets are measured at fair value at each 
reporting date, with any movement in fair value taken to profit or loss 
for the year.

18. SHARE BASED PAYMENTS 

OPTIONS
The Company operates an equity settled share based remuneration 
scheme for directors, employees and advisors. Under the director and 
employees’ scheme, options issued during the year were granted to 
purchase shares which must be exercised within ten years from the 
date of the grant.
The options are capable of exercise on the third anniversary of the 
grant date according to the increase in share price on the vesting 
date. If at any point prior to the third anniversary of the grant date, 
the share price increases by 100%, then 100% of the shares vest 
immediately. If there has been no increase in share price by the third 
anniversary, then 0% of the shares vest. Between these two points the 
options will vest on a straight-line basis. 

Under the previous scheme, which is still in place for the non-
executive director and previous directors, shares were granted which 
must be exercised within seven years from the date of grant. These 
options vest immediately on issue.

In 2017 share options were issued to a professional adviser as part 
of their fees. Under the advisors’ scheme options may be granted 
to purchase shares which must be exercised within ten years from 
the date of grant. The advisor options are fully vested and the 2015 
options have now lapsed.

The Black Scholes method was used to calculate the fair value of the 
director and employees’ scheme to calculate the fair value of options 
at the date of grant.

A total share based payment charge of £27,456 was recognised in 2021 
(2020: £109,455) in respect of the options granted in 2019 and 2020, of 
this £(6,732) (2019: £23,987) related to equity settled options issued to 
employees. A small adjustment was made to the employee share based 
payment in 2021 due to a slight overcharge in 2020. 

The table below lists the inputs to the model used for the options 
granted in 2020:

Weighted average share price at date of grant 

Weighted average exercise price 

Expected volatility 

Vesting period 

Contractual life 

Risk free rate 

The share options held as at 31 December 2021 are set out in the table below:

EMPLOYEES

8.15 pence

8.15 pence

100%

3

10

1.94%

31 DECEMBER 2021 

LEVEL 1 

LEVEL 2 

LEVEL 3 

TOTAL

Outstanding at  
31 December 2020

Granted  
during the year

Exercised  
during the year

Lapsed during  
the year

Outstanding at  
31 December 2021

Option  
Price

Exercisable 
on or before

Investments held for trading 

8,746,157 

– 

21,865,890 

30,612,047

Directors 

7,500,000 

31 DECEMBER 2020 

LEVEL 1 

LEVEL 2 

LEVEL 3 

TOTAL

Investments held for trading 

– 

– 

21,904,791 

21,904,791

See note 11 for more detail.

250,000 

2,500,000 

Total directors 

10,250,000 

Employees 

500,000 

Other 

900,000 

100,000 

Total Options 

11,750,000 

– 

– 

– 

– 

– 

– 

– 

– 

– 

– 

– 

– 

– 

400,000 

– 

400,000 

– 

– 

– 

– 

– 

– 

– 

– 

7,500,000 

8.5p 

18 May 2027

250,000 

13p 

22 Feb 2023

2,500,000 

9.15p 

1 Dec 2029

10,250,000 

500,000 

8.15p  22 July 2030

500,000 

9p 

15 Feb 2022

100,000 

8.5p 

18 May 2027

11,350,000 

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  64

Note: A detailed breakdown of directors’ options is set out in the Report on Directors’ Remuneration.

 
   
  
 
 
 
 
 
 
Notes to the Financial Statements
For the year ended 31 December 2021

19. RELATED PARTY TRANSACTIONS

20. CASH FLOW FROM OPERATIONS

The Company considers the following businesses to be related parties and details in 
the table below, all related party transactions that took place during the year.

FOR THE PERIOD AS AT 31 DECEMBER

2021 

Sales  
£ 

Purchases 
£ 

Investment 
£ 

Sales 
£ 

Purchases 
£ 

Investment 
£

2020  

Device Authority Limited  

24,333 

738 

1,172,511 

32,000 

Wyld Networks AB 

Wyld Networks Limited 

Wyld Technologies Limited 

- 

6,450 

6,000 

FVRVS Limited (FundamentalVR) 

10,000 

InVMA Limited (Konektio) 

Talking Medicines Limited 

12,000 

5,000 

- 

- 

- 

- 

- 

- 

451,674 

- 

- 

- 

31,025 

13,350 

530,000 

16,938 

350,000 

48,156 

- 

30,000 

- 

- 

- 

- 

- 

- 

- 

527,247

-

445,000

-

-

125,000

860,001

Outstanding trade receivable balances at the year-end are detailed in the table below:

AS AT 31 DECEMBER 

2021  

2020 

£ 

£

Device Authority Limited  

90,959 

83,844

FVRVS Limited (FundamentalVR) 

12,000 

-

InVMA Limited (Konektio) 

- 

82,720

Equity shareholdings are detailed in Note 11. 

Profit for the year 

ADJUSTMENTS FOR ITEMS NOT INCLUDED IN CASH FLOW 

2021 
£ 

2020
£

4,578,321 

803,891

Movement in fair value of investments 

(6,240,095) 

(1,992,891)

Loss on disposal 

Deferred cash on sale of investment 

Share based payment charge 

Finance income 

Operating cash flows before movements in working capital 

ADJUSTMENTS FOR CHANGES IN WORKING CAPITAL 

Decrease/(increase) in trade and other receivables 1  

Increase in trade and other payables 

Cash used in operations 

1 Excludes interest receivable from investments.

199,115 

– 

27,456 

(183,988) 

(1,619,191) 

37,015 

46,454 

–

6,060

109,455

(208,488)

(1,281,973)

(51,075)

143,567

(1,535,722) 

(1,189,481)

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  66

 
 
 
 
 
 
 
 
 
 
  
 
  
 
Notes to the Financial Statements
For the year ended 31 December 2021

21. FINANCIAL INSTRUMENTS
The Company uses financial instruments, other than derivatives, comprising cash to provide funding for the Company’s operations.

CATEGORIES OF FINANCIAL INSTRUMENTS
The IFRS 9 categories of financial asset included in the Statement of Financial Position and the headings in which they are included are  
as follows, all of which are current:

FINANCIAL ASSETS 

Cash at bank 

Financial instruments at amortised cost 

Trade receivables 

Other receivables 

Fair value through profit or loss (FVTPL) 

2021 
£ 

2020
£

1,957,203 

2,130,166

102,959 

21,737 

166,564

22,244

Investments 

30,612,047 

21,904,791

FINANCIAL LIABILITIES MEASURED AT AMORTISED COST: 
The IFRS 9 categories of financial liabilities included in the Statement of Financial Position and the headings in which they are included are as 
follows, all of which are current:

Trade payables 

Accruals 

2021 
£ 

75,232 

201,920 

2020
£

104,066

125,809

22. EVENTS AFTER THE REPORTING PERIOD
On 1 February 2022, it was announced that Talking Medicines Limited had completed a £1.6m equity fundraise at an increased valuation. The 
Company’s investment in Talking Medicines is now valued at £1.8m, which included an additional investment of £0.4m by Tern in this round.

On 2 March 2022, it was announced that Tern has agreed to participate in a new venture capital fund, the Sure Valley Ventures UK Software 
Technology Fund alongside the British Business Bank and other investors. Tern will initially invest approximately £90,000 and has committed to 
invest up to £5m in total over the 10-year life of the fund, which would equate to a c.5.9% interest.

23. ULTIMATE CONTROLLING PARTY
The directors do not consider there to be a single ultimate controlling party.

www.ternplc.com

© Tern PLC: All Rights Reserved 2022  68

 
 
  
 
  
 
  
 
  
 
  
 
Notice of 2022  
Annual General Meeting

Notice of 2022 Annual General Meeting
NOTICE IS HEREBY GIVEN that the 
2022 Annual General Meeting of Tern plc 
(“the Company”) will be held at 9.30am 
on Wednesday 27 April 2022 at the offices 
of Reed Smith, The Broadgate Tower, 20 
Primrose Street, London, EC2A 2RS. 

COVID-19 Arrangements
While it is currently anticipated that there will 
be no restrictions on social contact or meeting 
format at the time of the AGM, shareholders 
should carefully consider whether or not it is 
appropriate to attend the AGM. The Board 
remains keen to ensure the wellbeing of all 
employees and shareholders is protected and 
to minimise any public health risks from 
public gatherings. Shareholders are strongly 
encouraged to exercise their voting rights by 
completing and submitting a Form of Proxy 
in advance of the meeting, appointing the 
Chairman of the Annual General Meeting 
as proxy rather than a named person. 
Shareholders are asked not to attend the 
AGM if they are displaying any symptoms 
of COVID-19, or have recently been in 
contact with anyone who has tested positive. 
To minimise transmission we encourage 
shareholders to take a rapid lateral flow test 
before attending the meeting, and subject 
to conditions on the day of the meeting, 
shareholders may be required to wear face 
masks.

The Company will continue to closely 
monitor the developing impact of COVID-19, 
including the latest UK Government guidance. 
If a change to Government guidelines is 
announced after the date of this Notice is 
published and such guidelines limit gatherings 
and shareholder attendance at the AGM, 
any changes to the AGM arrangements 
will be notifed to shareholders through the 
Company’s website www.ternplc.com and, 
where appropriate, by announcement made 
by the Company to a Regulatory Information 
Service.

ORDINARY BUSINESS
To consider, and if thought fit, to pass the 
following resolutions as ordinary resolutions:

1. To receive and adopt the Company’s annual 
accounts for the financial year ended 31 
December 2021, together with the Directors’ 
Report and Auditors’ Report on those 
accounts.

www.ternplc.com

2. To re-appoint Nexia Smith & Williamson 
as auditors to hold office from the conclusion 
of the meeting to the conclusion of the next 
meeting at which the accounts are laid 
before the Company at a remuneration to be 
determined by the directors.

3. Sarah Payne retires by rotation, in 
accordance with the Articles of Association 
of the Company and having consented to be 
considered for re-appointment, is hereby re-
appointed as a director of the Company.

4. Alan Howarth retires by rotation, in 
accordance with the Articles of Association 
of the Company and having consented to be 
considered for re-appointment, is hereby re-
appointed as a director of the Company.

SPECIAL BUSINESS
To consider, and if thought fit, to pass the 
following resolutions, of which resolution 5 
will be proposed as an ordinary resolution and 
resolutions 6 and 7 will be proposed as special 
resolutions:

5. That for the purpose of section 551 of the 
Companies Act 2006 (the Act) the directors 
of the Company be and are hereby generally 
and unconditionally authorised to exercise 
all powers of the Company to allot equity 
securities (within the meaning of Section 
560 of the Act) up to an aggregate nominal 
amount of £12,500 provided that this authority 
shall expire (unless previously renewed, 
varied or revoked by the Company in general 
meeting) at the conclusion of the next annual 
general meeting of the Company, save that 
the Company may before such expiry make 
an offer or agreement which would or might 
require relevant equity securities to be allotted 
after such expiry and the board may allot 
relevant equity securities in pursuance of 
such an offer or agreement as if the authority 
conferred hereby had not expired.

This authority is in substitution for all 
subsisting authorities previously conferred upon 
the directors for the purposes of section 551 of 
the Act, without prejudice to any allotments 
made pursuant to the terms of such authorities.

6. That, subject to the passing of resolution 5 
above, the directors of the Company be and 
are hereby empowered pursuant to section 570 
of the Act to allot equity securities (within the 
meaning of section 560 of the Act) pursuant to 
the authority conferred by resolution 5 above 
as if section 561 of the Act did not apply to 

any such allotment provided that the power 
conferred by this resolution shall be limited to:

6.1 the allotment of equity securities for cash 
in connection with an issue or offer of equity 
securities (including,
without limitation, under a rights issue, open 
offer or similar arrangement) to holders of 
equity securities in proportion (as nearly as 
may be practicable) to their respective holdings 
of equity securities subject only to such 
exclusions or other arrangements as the board 
may consider necessary or expedient to deal 
with fractional entitlements or legal or practical 
problems under the laws of any territory, or the 
requirements of any regulatory body or stock 
exchange in any territory; and

6.2 the allotment (otherwise than pursuant 
to sub-paragraph 6.1 of this resolution (6) of 
equity securities up to an aggregate nominal 
value of £10,000.

The power conferred by this resolution 6 shall 
expire (unless previously renewed, revoked or 
varied by the Company in general meeting), at 
such time as the general authority conferred on 
the board by resolution 5 above expires, except 
that the Company may at any time before such 
expiry make any offer or agreement which 
would or might require equity securities to be 
allotted after such expiry and the directors of 
the Company may allot or sell equity securities 
for cash in pursuance of such an offer or 
agreement as if the authority conferred hereby 
had not expired.

7. That the Company be and is hereby generally 
and unconditionally authorised to make market 
purchases (within the meaning of section 
693(4) of the 2006 Act) of its Ordinary Shares 
provided that:

7.1 the maximum number of Ordinary Shares 
authorised to be purchased is 10% of the entire 
issued share capital of the Company;

7.2 the minimum price which may be paid for 
an Ordinary Share is £0.0002;

7.3 the maximum price which may be paid for 
an Ordinary Share is an amount equal to 105% 
of the average of the middle-market prices 
shown in the quotation for an Ordinary Share 
as derived from the Stock Exchange Alternative 
Trading Service of the Stock Exchange for the 
5 business days immediately preceding the day 
on which the Ordinary Share is purchased;

7.4 the authority hereby conferred shall expire 
on the earlier of the date falling 15 months 
after the Annual General Meeting or on the 
conclusion of the next annual general meeting 
of the Company to be held in 2023; and

7.5 the Company may make a contract to 
purchase its Ordinary Shares under the 
authority hereby conferred prior to the expiry 
of such authority, which contract will or may 
be executed wholly or partly after the expiry 
of such contract.

By Order of the Board
Sarah Payne,
Company Secretary
23 March 2022

NOTES TO THE AGM NOTICE
1. Shareholders are strongly encouraged to 
exercise their voting rights by completing and 
submitting a Form of Proxy in advance of 
the meeting, appointing the Chairman of the 
Annual General Meeting as proxy rather than 
a named person.

2. In accordance with Regulation 41 of the 
Uncertificated Securities Regulations 2001 
and by paragraph 18(c) of The Companies Act 
(Consequential Amendments) (Uncertificated 
Securities) Order 2009, only those members 
entered on the Company’s register of members 
not later than 9.30am on 25 April 2022, or if 
the meeting is adjourned, Shareholders entered 
on the Company’s register of members not 
later than 2 days before the time fixed for the 
adjourned meeting (excluding non-business 
days) shall be entitled to attend and vote at the 
meeting.

3. A member of the Company entitled to attend 
and vote at this meeting is entitled to appoint a 
proxy (or proxies) to vote in his place. A proxy 
need not be a member of the Company. You 
can only appoint a proxy using the procedures 
set out in these notes and the notes to the Form 
of Proxy.

4. To be effective, the Form of Proxy must 
be deposited at the office of the Company’s 
registrars, Share Registrars Limited, Molex 
House, The Millennium Centre, Crosby 
Way, Farnham, Surrey, GU9 7XX so as to be 
received not later than 9.30am on 25 April 
2022, or if the meeting is adjourned, not later 
than 48 hours before the time fixed for the 
adjourned meeting.

5. To change your proxy instructions simply 
submit a new proxy appointment using the 
methods set out above and in the notes to the 
Form of Proxy. Note that the cut-off times for 
receipt of proxy appointments (see above) also 
apply in relation to amended instructions; any 
amended proxy appointment received after the 
relevant cut-off time will be disregarded.
Where you have appointed a proxy and would 
like to change the instructions, please contact 
the Company’s registrars, Share Registrars 
Limited, Molex House, The Millennium 
Centre, Crosby Way, Farnham, Surrey,  
GU9 7XX.

6. In order to revoke a proxy instruction, you 
will need to inform the Company by sending 
a signed hard copy notice clearly stating your 
intention to revoke your proxy appointment 
to the Company’s registrars, Share Registrars 
Limited, Molex House, The Millennium 
Centre, Crosby Way, Farnham, Surrey, 
GU9 7XX. In the case of a member which 
is a company, the revocation notice must be 
executed under its common seal or signed 
on its behalf by an officer of the company or 
an attorney for the company. Any power of 
attorney or any other authority under which 
the revocation notice is signed (or a duly 
certified copy of such power or authority) must 
be included with the revocation notice.

In either case, the revocation notice must 
be received by the Company’s registrars, 
Share Registrars Limited, Molex House, The 
Millennium Centre, Crosby Way, Farnham, 
Surrey, GU9 7XX no later than 9.30am on 25 
April 2022.

If you attempt to revoke your proxy 
appointment but the revocation is received 
after the time specified above, then your proxy 
appointment will remain valid.

7. CREST members who wish to appoint 
a proxy or proxies by utilising the CREST 
electronic proxy appointment service may do 
so by utilising the procedures described in the 
CREST Manual. CREST Personal Members 
or other CREST sponsored members, and 
those CREST members who have appointed a 
voting service provider(s), should refer to their 
CREST sponsor or voting service provider(s), 
who will be able to take the appropriate action 
on their behalf.

In order for a proxy appointment made by 
means of CREST to be valid, the appropriate 
CREST message (a ‘CREST Proxy 
Instruction’) must be properly authenticated 
in accordance with CRESTCo’s specifications 
and must contain the information required 
for such instructions, as described in the 
CREST Manual. The message, regardless 
of whether it relates to the appointment of a 
proxy or to an amendment to the instruction 
given to a previously appointed proxy must, 
in order to be valid, be transmitted so as to 
be received by our agent Share Registrars (ID 
7RA36) by the latest time(s) for receipt of 
proxy appointments specified in the notice of 
meeting. For this purpose, the time of receipt 
will be taken to be the time (as determined 
by the timestamp applied to the message by 
the CREST Applications Host) from which 
the issuer’s agent is able to retrieve the 
message by enquiry to CREST in the manner 
prescribed by CREST. The Company may 
treat as invalid a CREST Proxy Instruction in 
the circumstances set out in Regulation 35(5)
(a) of the Uncertificated Securities Regulations 
2001.

CREST members and, where applicable, their 
CREST sponsors or voting service providers 
should note that CRESTCo does not make 
available special procedures in CREST for any 
particular messages. Normal system timings 
and limitations will therefore apply in relation 
to the input of CREST Proxy Instructions. It 
is the responsibility of the CREST member 
concerned to take (or, if the CREST member 
is a CREST personal member or sponsored 
member or has appointed a voting service 
provider(s), to procure that his CREST sponsor 
or voting service provider(s) take(s)) such 
action as shall be necessary to ensure that 
a message is transmitted by means of the 
CREST system by any particular time. In 
this connection, CREST members and, where 
applicable, their CREST sponsors or voting 
service providers are referred, in particular, 
to those sections of the CREST Manual 
concerning practical limitations of the CREST 
system and timings.

© Tern PLC: All Rights Reserved 2022  70

Company Information

REGISTRARS
Share Registrars Limited
Molex House
The Millennium Centre
Crosby Way
Farnham
Surrey
GU9 7XX

BANKERS 
Handelsbanken plc
3rd Floor
86 Jermyn Street
London
SW1Y 6JD

CORPORATE LAWYERS 
Reed Smith LLP
The Broadgate Tower
20 Primrose Street
London EC2A 2RS

DIRECTORS 
Ian Ritchie 
Albert Sisto 
Sarah Payne 
Bruce Leith 
Alan Howarth 
Matthew Scherba

SECRETARY
Sarah Payne

REGISTERED OFFICE
27/28 Eastcastle Street
London
W1W 8DH

COMPANY’S REGISTERED NUMBER
5131386

AUDITOR 
Nexia Smith & Williamson
25 Moorgate
London
EC2R 6AY

NOMINATED ADVISER AND BROKER
Allenby Capital Limited
5 St. Helen’s Place
London
EC3A 6AB

© Tern PLC: All Rights Reserved 2022  72